{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T00:32:23Z","timestamp":1792801943049,"version":"4.5.0"},"reference-count":280,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2024,3,30]],"date-time":"2024-03-30T00:00:00Z","timestamp":1711756800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,3,30]],"date-time":"2024-03-30T00:00:00Z","timestamp":1711756800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100012681","name":"Universit\u00e4tsklinikum K\u00f6ln","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100012681","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neurol"],"published-print":{"date-parts":[[2024,6]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Tauopathies are a heterogeneous group of neurologic diseases characterized by pathological axodendritic distribution, ectopic expression, and\/or phosphorylation and aggregation of the microtubule-associated protein TAU, encoded by\u00a0the gene <jats:italic>MAPT<\/jats:italic>. Neuronal dysfunction, dementia, and neurodegeneration are common features of these often detrimental diseases. A neurodegenerative disease is considered a primary tauopathy when <jats:italic>MAPT<\/jats:italic> mutations\/haplotypes are its primary cause and\/or TAU is the main pathological feature. In case TAU pathology is observed but superimposed by another pathological hallmark, the condition is classified as a secondary tauopathy. In some tauopathies (e.g. <jats:italic>MAPT<\/jats:italic>-associated frontotemporal dementia (FTD), progressive supranuclear palsy (PSP), corticobasal degeneration (CBD), and Alzheimer's disease (AD)) TAU is recognized as a significant pathogenic driver of the disease. In many secondary tauopathies, including Parkinson's disease (PD) and Huntington's disease (HD), TAU is suggested to contribute to the development of dementia, but in others (e.g. Niemann-Pick disease (NPC)) TAU may only be a bystander. The genetic and pathological mechanisms underlying TAU pathology are often not fully understood. In this review, the genetic predispositions and variants associated with both primary and secondary tauopathies are examined in detail, assessing evidence for the role of TAU in these conditions. We highlight less common genetic forms of tauopathies to increase awareness for these disorders and the involvement of TAU in their pathology. This approach not only contributes to a deeper understanding of these conditions but may also lay the groundwork for potential TAU-based therapeutic interventions for various tauopathies.<\/jats:p>","DOI":"10.1007\/s00415-024-12314-3","type":"journal-article","created":{"date-parts":[[2024,3,30]],"date-time":"2024-03-30T09:01:43Z","timestamp":1711789303000},"page":"2992-3018","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":45,"title":["Genetic forms of tauopathies: inherited causes and implications of Alzheimer\u2019s disease-like TAU pathology in primary and secondary tauopathies"],"prefix":"10.1007","volume":"271","author":[{"ORCID":"https:\/\/orcid.org\/0009-0007-5379-9089","authenticated-orcid":false,"given":"Felix","family":"Langerscheidt","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-1777-6619","authenticated-orcid":false,"given":"Tamara","family":"Wied","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6200-2448","authenticated-orcid":false,"given":"Mohamed Aghyad","family":"Al Kabbani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6951-2325","authenticated-orcid":false,"given":"Thilo","family":"van Eimeren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5544-335X","authenticated-orcid":false,"given":"Gilbert","family":"Wunderlich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7510-3077","authenticated-orcid":false,"given":"Hans","family":"Zempel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,3,30]]},"reference":[{"key":"12314_CR1","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1146\/annurev-pathmechdis-012418-012936","volume":"14","author":"J G\u00f6tz","year":"2019","unstructured":"G\u00f6tz J, Halliday G, Nisbet RM (2019) Molecular pathogenesis of the tauopathies. Annu Rev Pathol 14:239\u2013261. https:\/\/doi.org\/10.1146\/annurev-pathmechdis-012418-012936","journal-title":"Annu Rev Pathol"},{"key":"12314_CR2","doi-asserted-by":"publisher","first-page":"5","DOI":"10.3390\/cells10113064","volume":"10","author":"G Zimmer-Bensch","year":"2021","unstructured":"Zimmer-Bensch G, Zempel H (2021) Dna methylation in genetic and sporadic forms of neurodegeneration: lessons from Alzheimer\u2019s, related tauopathies and genetic tauopathies. Cells 10:5. https:\/\/doi.org\/10.3390\/cells10113064","journal-title":"Cells"},{"key":"12314_CR3","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1007\/s00401-017-1707-9","volume":"133","author":"T Guo","year":"2017","unstructured":"Guo T, Noble W, Hanger DP (2017) Roles of tau protein in health and disease. Acta Neuropathol 133:665\u2013704. https:\/\/doi.org\/10.1007\/s00401-017-1707-9","journal-title":"Acta Neuropathol"},{"key":"12314_CR4","doi-asserted-by":"publisher","first-page":"1220","DOI":"10.1002\/jcp.22842","volume":"227","author":"A Andreadis","year":"2012","unstructured":"Andreadis A (2012) Tau splicing and the intricacies of dementia. J Cell Physiol 227:1220\u20131225. https:\/\/doi.org\/10.1002\/jcp.22842","journal-title":"J Cell Physiol"},{"key":"12314_CR5","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1016\/0896-6273(89)90210-9","volume":"3","author":"M Goedert","year":"1989","unstructured":"Goedert M, Spillantini MG, Jakes R, Rutherford D, Crowther RA (1989) Multiple isoforms of human microtubule-associated protein tau: sequences and localization in neurofibrillary tangles of Alzheimer\u2019s disease. Neuron 3:519\u2013526. https:\/\/doi.org\/10.1016\/0896-6273(89)90210-9","journal-title":"Neuron"},{"key":"12314_CR6","doi-asserted-by":"publisher","first-page":"1983","DOI":"10.1073\/pnas.89.5.1983","volume":"89","author":"M Goedert","year":"1992","unstructured":"Goedert M, Spillantini MG, Crowther RA (1992) Cloning of a big tau microtubule-associated protein characteristic of the peripheral nervous system. Proc Natl Acad Sci 89:1983\u20131987. https:\/\/doi.org\/10.1073\/pnas.89.5.1983","journal-title":"Proc Natl Acad Sci"},{"key":"12314_CR7","doi-asserted-by":"publisher","first-page":"ENEURO.0052-23.","DOI":"10.1523\/ENEURO.0052-23.2023","volume":"10","author":"I Fischer","year":"2023","unstructured":"Fischer I (2023) Big tau: what we know, and we need to know. Eneuro 10:ENEURO.0052-23.2023. https:\/\/doi.org\/10.1523\/ENEURO.0052-23.2023","journal-title":"Eneuro"},{"key":"12314_CR8","doi-asserted-by":"crossref","unstructured":"Zempel H, Mandelkow E (2019) Mechanisms of axonal sorting of tau and influence of the axon initial segment on tau cell polarity. pp 69\u201377","DOI":"10.1007\/978-981-32-9358-8_6"},{"key":"12314_CR9","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1016\/j.tins.2014.08.004","volume":"37","author":"H Zempel","year":"2014","unstructured":"Zempel H, Mandelkow E (2014) Lost after translation: missorting of tau protein and consequences for Alzheimer disease. Trends Neurosci 37:721\u2013732. https:\/\/doi.org\/10.1016\/j.tins.2014.08.004","journal-title":"Trends Neurosci"},{"key":"12314_CR10","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1111\/nan.12792","volume":"48","author":"GG Kovacs","year":"2022","unstructured":"Kovacs GG, Ghetti B, Goedert M (2022) Classification of diseases with accumulation of tau protein. Neuropathol Appl Neurobiol 48:5. https:\/\/doi.org\/10.1111\/nan.12792","journal-title":"Neuropathol Appl Neurobiol"},{"key":"12314_CR11","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1101\/sqb.2018.83.037580","volume":"83","author":"M Goedert","year":"2018","unstructured":"Goedert M, Falcon B, Zhang W, Ghetti B, Scheres SHW (2018) Distinct conformers of assembled tau in Alzheimer\u2019s and Pick\u2019s diseases. Cold Spring Harb Symp Quant Biol 83:163\u2013171. https:\/\/doi.org\/10.1101\/sqb.2018.83.037580","journal-title":"Cold Spring Harb Symp Quant Biol"},{"key":"12314_CR12","doi-asserted-by":"publisher","first-page":"988","DOI":"10.1002\/alz.12452","volume":"18","author":"C Sexton","year":"2022","unstructured":"Sexton C, Snyder H, Beher D, Boxer AL, Brannelly P, Brion J, Bu\u00e9e L, Cacace AM, Ch\u00e9telat G, Citron M, DeVos SL, Diaz K, Feldman HH, Frost B, Goate AM, Gold M, Hyman B, Johnson K, Karch CM, Kerwin DR, Koroshetz WJ, Litvan I, Morris HR, Mummery CJ, Mutamba J, Patterson MC, Quiroz YT, Rabinovici GD, Rommel A, Shulman MB, Toledo-Sherman LM, Weninger S, Wildsmith KR, Worley SL, Carrillo MC (2022) Current directions in tau research: highlights from tau 2020. Alzheimer\u2019s Dementia 18:988\u20131007. https:\/\/doi.org\/10.1002\/alz.12452","journal-title":"Alzheimer\u2019s Dementia"},{"key":"12314_CR13","doi-asserted-by":"publisher","first-page":"2111","DOI":"10.1007\/s10072-020-04901-9","volume":"42","author":"P Caroppo","year":"2021","unstructured":"Caroppo P, Prioni S, Maderna E, Grisoli M, Rossi G (2021) New MAPT variant in a FTD patient with Alzheimer\u2019s disease phenotype at onset. Neurol Sci 42:2111\u20132114. https:\/\/doi.org\/10.1007\/s10072-020-04901-9","journal-title":"Neurol Sci"},{"key":"12314_CR14","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1186\/s13024-022-00533-z","volume":"17","author":"Y Zhang","year":"2022","unstructured":"Zhang Y, Wu K-M, Yang L, Dong Q, Yu J-T (2022) Tauopathies: new perspectives and challenges. Mol Neurodegener 17:28. https:\/\/doi.org\/10.1186\/s13024-022-00533-z","journal-title":"Mol Neurodegener"},{"key":"12314_CR15","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1038\/nature13800","volume":"515","author":"SH Choi","year":"2014","unstructured":"Choi SH, Kim YH, Hebisch M, Sliwinski C, Lee S, D\u2019Avanzo C, Chen H, Hooli B, Asselin C, Muffat J, Klee JB, Zhang C, Wainger BJ, Peitz M, Kovacs DM, Woolf CJ, Wagner SL, Tanzi RE, Kim DY (2014) A Three-dimensional human neural cell culture model of Alzheimer\u2019s disease. Nature 515:274\u2013278. https:\/\/doi.org\/10.1038\/nature13800","journal-title":"Nature"},{"key":"12314_CR16","doi-asserted-by":"publisher","first-page":"2363","DOI":"10.1038\/s41380-018-0229-8","volume":"23","author":"C Gonzalez","year":"2018","unstructured":"Gonzalez C, Armijo E, Bravo-Alegria J, Becerra-Calixto A, Mays CE, Soto C (2018) Modeling amyloid beta and tau pathology in human cerebral organoids. Mol Psychiatry 23:2363\u20132374. https:\/\/doi.org\/10.1038\/s41380-018-0229-8","journal-title":"Mol Psychiatry"},{"key":"12314_CR17","doi-asserted-by":"publisher","first-page":"2920","DOI":"10.1038\/emboj.2013.207","volume":"32","author":"H Zempel","year":"2013","unstructured":"Zempel H, Luedtke J, Kumar Y, Biernat J, Dawson H, Mandelkow E, Mandelkow E-M (2013) Amyloid-\u03b2 oligomers induce synaptic damage via tau-dependent microtubule severing by TTLL6 and spastin. EMBO J 32:2920\u20132937. https:\/\/doi.org\/10.1038\/emboj.2013.207","journal-title":"EMBO J"},{"key":"12314_CR18","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1016\/j.brainresbull.2016.08.018","volume":"126","author":"T Arendt","year":"2016","unstructured":"Arendt T, Stieler JT, Holzer M (2016) Tau and tauopathies. Brain Res Bull 126:238\u2013292. https:\/\/doi.org\/10.1016\/j.brainresbull.2016.08.018","journal-title":"Brain Res Bull"},{"key":"12314_CR19","doi-asserted-by":"publisher","first-page":"5","DOI":"10.3389\/fnagi.2023.1164581","volume":"15","author":"R Keszycki","year":"2023","unstructured":"Keszycki R, Kawles A, Minogue G, Zouridakis A, Macomber A, Gill N, Vu M, Zhang H, Coventry C, Rogalski E, Weintraub S, Mesulam M-M, Geula C, Gefen T (2023) Distinct and shared neuropsychiatric phenotypes in FTLD-tauopathies. Front Aging Neurosci 15:5. https:\/\/doi.org\/10.3389\/fnagi.2023.1164581","journal-title":"Front Aging Neurosci"},{"key":"12314_CR20","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1186\/s13024-021-00476-x","volume":"16","author":"DC Chung","year":"2021","unstructured":"Chung DC, Roemer S, Petrucelli L, Dickson DW (2021) Cellular and pathological heterogeneity of primary tauopathies. Mol Neurodegener 16:57. https:\/\/doi.org\/10.1186\/s13024-021-00476-x","journal-title":"Mol Neurodegener"},{"key":"12314_CR21","doi-asserted-by":"publisher","DOI":"10.1016\/j.pneurobio.2019.101644","author":"TW R\u00f6sler","year":"2019","unstructured":"R\u00f6sler TW, Tayaranian Marvian A, Brendel M, Nyk\u00e4nen NP, H\u00f6llerhage M, Schwarz SC, Hopfner F, Koeglsperger T, Respondek G, Schweyer K, Levin J, Villemagne VL, Barthel H, Sabri O, M\u00fcller U, Meissner WG, Kovacs GG, H\u00f6glinger GU (2019) Four-repeat tauopathies. Progress Neurobiol, Elsevier Ltd. https:\/\/doi.org\/10.1016\/j.pneurobio.2019.101644","journal-title":"Progress Neurobiol, Elsevier Ltd"},{"key":"12314_CR22","doi-asserted-by":"publisher","DOI":"10.33590\/emjneurol\/10314777","author":"G Kovacs","year":"2014","unstructured":"Kovacs G (2014) Current concepts of neurodegenerative diseases. EMJ Neurology. https:\/\/doi.org\/10.33590\/emjneurol\/10314777","journal-title":"EMJ Neurology"},{"key":"12314_CR23","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1111\/nan.12208","volume":"41","author":"G Kovacs","year":"2015","unstructured":"Kovacs G (2015) Invited review: neuropathology of tauopathies: principles and practice. Neuropathol Appl Neurobiol 41:3\u201323. https:\/\/doi.org\/10.1111\/nan.12208","journal-title":"Neuropathol Appl Neurobiol"},{"key":"12314_CR24","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1007\/s00401-015-1509-x","volume":"131","author":"G Kovacs","year":"2016","unstructured":"Kovacs G, Ferrer I, Grinberg LT, Alafuzoff I, Attems J, Budka H, Cairns NJ, Crary JF, Duyckaerts C, Ghetti B, Halliday GM, Ironside JW, Love S, Mackenzie IR, Munoz DG, Murray ME, Nelson PT, Takahashi H, Trojanowski JQ, Ansorge O, Arzberger T, Baborie A, Beach TG, Bieniek KF, Bigio EH, Bodi I, Dugger BN, Feany M, Gelpi E, Gentleman SM, Giaccone G, Hatanpaa KJ, Heale R, Hof PR, Hofer M, Hortob\u00e1gyi T, Jellinger K, Jicha GA, Ince P, Kofler J, K\u00f6vari E, Kril JJ, Mann DM, Matej R, McKee AC, McLean C, Milenkovic I, Montine TJ, Murayama S, Lee EB, Rahimi J, Rodriguez RD, Rozem\u00fcller A, Schneider JA, Schultz C, Seeley W, Seilhean D, Smith C, Tagliavini F, Takao M, Thal DR, Toledo JB, Tolnay M, Troncoso JC, Vinters HV, Weis S, Wharton SB, White CL, Wisniewski T, Woulfe JM, Yamada M, Dickson DW (2016) Aging-related tau astrogliopathy (ARTAG): harmonized evaluation strategy. Acta Neuropathol, Springer Verlag 131:87\u2013102. https:\/\/doi.org\/10.1007\/s00401-015-1509-x","journal-title":"Acta Neuropathol, Springer Verlag"},{"key":"12314_CR25","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1017\/CBO9781107588660","volume-title":"Introduction. Neuropathology of Neurodegenerative diseases","author":"G Kovacs","year":"2014","unstructured":"Kovacs G (2014) Introduction. Neuropathology of Neurodegenerative diseases. Cambridge University Press, pp 1\u20137"},{"key":"12314_CR26","doi-asserted-by":"publisher","first-page":"S29","DOI":"10.1016\/j.parkreldis.2015.09.020","volume":"22","author":"DJ Irwin","year":"2016","unstructured":"Irwin DJ (2016) Tauopathies as clinicopathological entities. Parkinsonism Relat Disord Elsevier Ltd 22:S29\u2013S33. https:\/\/doi.org\/10.1016\/j.parkreldis.2015.09.020","journal-title":"Parkinsonism Relat Disord Elsevier Ltd"},{"key":"12314_CR27","doi-asserted-by":"publisher","DOI":"10.3389\/fnagi.2015.00171","author":"A Benussi","year":"2015","unstructured":"Benussi A, Padovani A, Borroni B (2015) Phenotypic heterogeneity of monogenic frontotemporal dementia. Front Aging Neurosci. https:\/\/doi.org\/10.3389\/fnagi.2015.00171","journal-title":"Front Aging Neurosci"},{"key":"12314_CR28","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1002\/alz.12414","volume":"18","author":"B Borroni","year":"2022","unstructured":"Borroni B, Graff C, Hardiman O, Ludolph AC, Moreno F, Otto M, Piccininni M, Remes AM, Rowe JB, Seelaar H, Stefanova E, Traykov L, Logroscino G (2022) FRONTotemporal dementia incidence european research study\u2014FRONTIERS: rationale and design. Alzheimer\u2019s Dementia 18:498\u2013506. https:\/\/doi.org\/10.1002\/alz.12414","journal-title":"Alzheimer\u2019s Dementia"},{"key":"12314_CR29","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1016\/j.bbadis.2004.08.007","volume":"1739","author":"M Goedert","year":"2005","unstructured":"Goedert M, Jakes R (2005) Mutations causing neurodegenerative tauopathies. Biochimica et Biophysica Acta BBA Mol Basis Dis 1739:240\u2013250. https:\/\/doi.org\/10.1016\/j.bbadis.2004.08.007","journal-title":"Biochimica et Biophysica Acta BBA Mol Basis Dis"},{"key":"12314_CR30","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2019.17363","volume":"2","author":"SL Garrett","year":"2019","unstructured":"Garrett SL, McDaniel D, Obideen M, Trammell AR, Shaw LM, Goldstein FC, Hajjar I (2019) Racial disparity in cerebrospinal fluid amyloid and tau biomarkers and associated cutoffs for mild cognitive impairment. JAMA Netw Open 2:e1917363. https:\/\/doi.org\/10.1001\/jamanetworkopen.2019.17363","journal-title":"JAMA Netw Open"},{"key":"12314_CR31","doi-asserted-by":"publisher","first-page":"12841","DOI":"10.3390\/ijms232112841","volume":"23","author":"P Rawat","year":"2022","unstructured":"Rawat P, Sehar U, Bisht J, Selman A, Culberson J, Reddy PH (2022) Phosphorylated tau in Alzheimer\u2019s disease and other tauopathies. Int J Mol Sci 23:12841. https:\/\/doi.org\/10.3390\/ijms232112841","journal-title":"Int J Mol Sci"},{"key":"12314_CR32","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1016\/S0014-5793(98)01217-4","volume":"437","author":"M Hasegawa","year":"1998","unstructured":"Hasegawa M, Smith MJ, Goedert M (1998) Tau proteins with FTDP-17 mutations have a reduced ability to promote microtubule assembly. FEBS Lett 437:207\u2013210. https:\/\/doi.org\/10.1016\/S0014-5793(98)01217-4","journal-title":"FEBS Lett"},{"key":"12314_CR33","doi-asserted-by":"publisher","first-page":"1914","DOI":"10.1126\/science.282.5395.1914","volume":"282","author":"M Hong","year":"1998","unstructured":"Hong M, Zhukareva V, Vogelsberg-Ragaglia V, Wszolek Z, Miller B, Geschwind D, Bird T, McKeel D, Goate A, Morris J, Wilhelmsen K, Schellenberg G, Trojanowski J, Lee V (1998) Mutation-specific functional impairments in distinct tau isoforms of hereditary FTDP-17. Science 282:1914\u20131917. https:\/\/doi.org\/10.1126\/science.282.5395.1914","journal-title":"Science"},{"key":"12314_CR34","doi-asserted-by":"publisher","first-page":"1179","DOI":"10.1242\/jcs.114.6.1179","volume":"114","author":"HN Dawson","year":"2001","unstructured":"Dawson HN, Ferreira A, Eyster MV, Ghoshal N, Binder LI, Vitek MP (2001) Inhibition of neuronal maturation in primary hippocampal neurons from tau deficient mice. J Cell Sci 114:1179\u20131187. https:\/\/doi.org\/10.1242\/jcs.114.6.1179","journal-title":"J Cell Sci"},{"key":"12314_CR35","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1038\/369488a0","volume":"369","author":"A Harada","year":"1994","unstructured":"Harada A, Oguchi K, Okabe S, Kuno J, Terada S, Ohshima T, Sato-Yoshitake R, Takei Y, Noda T, Hirokawa N (1994) Altered microtubule organization in small-calibre axons of mice lacking tau protein. Nature 369:488\u2013491. https:\/\/doi.org\/10.1038\/369488a0","journal-title":"Nature"},{"key":"12314_CR36","doi-asserted-by":"publisher","first-page":"343.e1","DOI":"10.1016\/j.neurobiolaging.2021.05.010","volume":"106","author":"DA Olszewska","year":"2021","unstructured":"Olszewska DA, Fearon C, McGuigan C, McVeigh TP, Houlden H, Polke JM, Lawlor B, Coen R, Hutchinson M, Hutton M, Beausang A, Delon I, Brett F, Sevastou I, Seto-Salvia N, de Silva R, Lynch T (2021) A clinical, molecular genetics and pathological study of a FTDP-17 family with a heterozygous splicing variant c.823-10G>T at the intron 9\/exon 10 of the MAPT gene. Neurobiol Aging 106:343.e1-343.e8. https:\/\/doi.org\/10.1016\/j.neurobiolaging.2021.05.010","journal-title":"Neurobiol Aging"},{"key":"12314_CR37","doi-asserted-by":"publisher","DOI":"10.3389\/fnagi.2015.00192","author":"G Rossi","year":"2015","unstructured":"Rossi G, Tagliavini F (2015) Frontotemporal lobar degeneration: old knowledge and new insight into the pathogenetic mechanisms of tau mutations. Front Aging Neurosci. https:\/\/doi.org\/10.3389\/fnagi.2015.00192","journal-title":"Front Aging Neurosci"},{"key":"12314_CR38","doi-asserted-by":"publisher","first-page":"175","DOI":"10.21037\/atm.2018.04.23","volume":"6","author":"Y-L Gao","year":"2018","unstructured":"Gao Y-L, Wang N, Sun F-R, Cao X-P, Zhang W, Yu J-T (2018) Tau in neurodegenerative disease. Ann Transl Med 6:175. https:\/\/doi.org\/10.21037\/atm.2018.04.23","journal-title":"Ann Transl Med"},{"key":"12314_CR39","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1083\/jcb.201007161","volume":"192","author":"A Gauthier-Kemper","year":"2011","unstructured":"Gauthier-Kemper A, Weissmann C, Golovyashkina N, Seb\u00f6-Lemke Z, Drewes G, Gerke V, Heinisch JJ, Brandt R (2011) The frontotemporal dementia mutation R406W Blocks Tau\u2019s interaction with the membrane in an annexin A2\u2013dependent manner. J Cell Biol 192:647\u2013661. https:\/\/doi.org\/10.1083\/jcb.201007161","journal-title":"J Cell Biol"},{"key":"12314_CR40","doi-asserted-by":"publisher","unstructured":"Iqbal K, Liu F, Gong C-X, Alonso A del C, Grundke-Iqbal I (2009) Mechanisms of tau-induced neurodegeneration. Acta Neuropathol 118:53\u201369. https:\/\/doi.org\/10.1007\/s00401-009-0486-3","DOI":"10.1007\/s00401-009-0486-3"},{"key":"12314_CR41","doi-asserted-by":"publisher","unstructured":"Alonso A del C, Mederlyova A, Novak M, Grundke-Iqbal I, Iqbal K (2004) Promotion of hyperphosphorylation by frontotemporal dementia tau mutations. J Biol Chem 279:34873\u201334881. https:\/\/doi.org\/10.1074\/jbc.M405131200","DOI":"10.1074\/jbc.M405131200"},{"key":"12314_CR42","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1016\/S0925-4439(00)00037-5","volume":"1502","author":"M Goedert","year":"2000","unstructured":"Goedert M, Spillantini MG (2000) Tau mutations in frontotemporal dementia FTDP-17 and their relevance for Alzheimer\u2019s disease. Biochimica et Biophysica Acta BBA Mol Basis Dis 1502:110\u2013121. https:\/\/doi.org\/10.1016\/S0925-4439(00)00037-5","journal-title":"Biochimica et Biophysica Acta BBA Mol Basis Dis"},{"key":"12314_CR43","doi-asserted-by":"publisher","first-page":"1008","DOI":"10.1002\/alz.12453","volume":"18","author":"BP Imbimbo","year":"2022","unstructured":"Imbimbo BP, Ippati S, Watling M, Balducci C (2022) A critical appraisal of tau-targeting therapies for primary and secondary tauopathies. Alzheimer\u2019s Dementia 18:1008\u20131037. https:\/\/doi.org\/10.1002\/alz.12453","journal-title":"Alzheimer\u2019s Dementia"},{"key":"12314_CR44","doi-asserted-by":"publisher","first-page":"2187","DOI":"10.1038\/s41591-023-02505-2","volume":"29","author":"WK Self","year":"2023","unstructured":"Self WK, Holtzman DM (2023) Emerging diagnostics and therapeutics for Alzheimer disease. Nat Med 29:2187\u20132199. https:\/\/doi.org\/10.1038\/s41591-023-02505-2","journal-title":"Nat Med"},{"key":"12314_CR45","doi-asserted-by":"publisher","DOI":"10.1016\/j.neurot.2023.10.001","volume":"21","author":"JR Roth","year":"2024","unstructured":"Roth JR, Rush T, Thompson SJ, Aldaher AR, Dunn TB, Mesina JS, Cochran JN, Boyle NR, Dean HB, Yang Z, Pathak V, Ruiz P, Wu M, Day JJ, Bostwick JR, Suto MJ, Augelli-Szafran CE, Roberson ED (2024) Development of small-molecule Tau-SH3 interaction inhibitors that prevent amyloid-\u03b2 toxicity and network hyperexcitability. Neurotherapeutics 21:e00291. https:\/\/doi.org\/10.1016\/j.neurot.2023.10.001","journal-title":"Neurotherapeutics"},{"key":"12314_CR46","doi-asserted-by":"publisher","DOI":"10.1126\/science.add6696","author":"Z-Y Zhang","year":"2023","unstructured":"Zhang Z-Y, Harischandra DS, Wang R, Ghaisas S, Zhao JY, McMonagle TP, Zhu G, Lacuarta KD, Song J, Trojanowski JQ, Xu H, Lee VM-Y, Yang X (2023) TRIM11 protects against tauopathies and is down-regulated in Alzheimer\u2019s disease. Science. https:\/\/doi.org\/10.1126\/science.add6696","journal-title":"Science"},{"key":"12314_CR47","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1038\/ng.859","volume":"43","author":"GU H\u00f6glinger","year":"2011","unstructured":"H\u00f6glinger GU, Melhem NM, Dickson DW, Sleiman PMA, Wang L-S, Klei L, Rademakers R, de Silva R, Litvan I, Riley DE, van Swieten JC, Heutink P, Wszolek ZK, Uitti RJ, Vandrovcova J, Hurtig HI, Gross RG, Maetzler W, Goldwurm S, Tolosa E, Borroni B, Pastor P, Cantwell LB, Han MR, Dillman A, van der Brug MP, Gibbs JR, Cookson MR, Hernandez DG, Singleton AB, Farrer MJ, Yu C-E, Golbe LI, Revesz T, Hardy J, Lees AJ, Devlin B, Hakonarson H, M\u00fcller U, Schellenberg GD (2011) Identification of common variants influencing risk of the tauopathy progressive supranuclear palsy. Nat Genet 43:699\u2013705. https:\/\/doi.org\/10.1038\/ng.859","journal-title":"Nat Genet"},{"key":"12314_CR48","doi-asserted-by":"publisher","DOI":"10.1186\/s40478-020-01097-z","author":"RR Valentino","year":"2020","unstructured":"Valentino RR, Koga S, Walton RL, Soto-Beasley AI, Kouri N, DeTure MA, Murray ME, Johnson PW, Petersen RC, Boeve BF, Uitti RJ, Wszolek ZK, Dickson DW, Ross OA, Heckman MG (2020) MAPT subhaplotypes in corticobasal degeneration: assessing associations with disease risk, severity of tau pathology, and clinical features. Acta Neuropathol Commun. https:\/\/doi.org\/10.1186\/s40478-020-01097-z","journal-title":"Acta Neuropathol Commun"},{"key":"12314_CR49","doi-asserted-by":"publisher","DOI":"10.3233\/JPD-202302","author":"Y Wen","year":"2021","unstructured":"Wen Y, Zhou Y, Jiao B, Shen L (2021) Genetics of progressive supranuclear palsy: a review. J Parkinson\u2019s Dis. https:\/\/doi.org\/10.3233\/JPD-202302","journal-title":"J Parkinson\u2019s Dis"},{"key":"12314_CR50","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1007\/BF00688244","volume":"77","author":"A Probst","year":"1988","unstructured":"Probst A, Langui D, Lautenschlager C, Ulrich J, Brion JP, Anderton BH (1988) Progressive supranuclear palsy: extensive neuropil threads in addition to neurofibrillary tangles. Acta Neuropathol 77:61\u201368. https:\/\/doi.org\/10.1007\/BF00688244","journal-title":"Acta Neuropathol"},{"key":"12314_CR51","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/0304-3940(92)90145-W","volume":"135","author":"T Yamada","year":"1992","unstructured":"Yamada T, McGeer PL, McGeer EG (1992) Appearance of paired nucleated, tau-positive glia in patients with progressive supranuclear palsy brain tissue. Neurosci Lett 135:99\u2013102. https:\/\/doi.org\/10.1016\/0304-3940(92)90145-W","journal-title":"Neurosci Lett"},{"key":"12314_CR52","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1136\/practneurol-2020-002794","volume":"21","author":"JB Rowe","year":"2021","unstructured":"Rowe JB, Holland N, Rittman T (2021) Progressive supranuclear palsy: diagnosis and management. Pract Neurol 21:376\u2013383. https:\/\/doi.org\/10.1136\/practneurol-2020-002794","journal-title":"Pract Neurol"},{"key":"12314_CR53","doi-asserted-by":"publisher","first-page":"e1004211","DOI":"10.1371\/journal.pgen.1004211","volume":"10","author":"Y Li","year":"2014","unstructured":"Li Y, Chen JA, Sears RL, Gao F, Klein ED, Karydas A, Geschwind MD, Rosen HJ, Boxer AL, Guo W, Pellegrini M, Horvath S, Miller BL, Geschwind DH, Coppola G (2014) An epigenetic signature in peripheral blood associated with the haplotype on 17q21.31, a risk factor for neurodegenerative tauopathy. PLoS Genet 10:e1004211. https:\/\/doi.org\/10.1371\/journal.pgen.1004211","journal-title":"PLoS Genet"},{"key":"12314_CR54","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1177\/09727531221089396","volume":"29","author":"M Debnath","year":"2022","unstructured":"Debnath M, Dey S, Sreenivas N, Pal PK, Yadav R (2022) Genetic and epigenetic constructs of progressive supranuclear palsy. Ann Neurosci 29:177\u2013188. https:\/\/doi.org\/10.1177\/09727531221089396","journal-title":"Ann Neurosci"},{"key":"12314_CR55","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/S1474-4422(20)30394-X","volume":"20","author":"E Jabbari","year":"2021","unstructured":"Jabbari E, Koga S, Valentino RR, Reynolds RH, Ferrari R, Tan MMX, Rowe JB, Dalgard CL, Scholz SW, Dickson DW, Warner TT, Revesz T, H\u00f6glinger GU, Ross OA, Ryten M, Hardy J, Shoai M, Morris HR, Mok KY, Murphy DP, Al-Sarraj S, Troakes C, Gentleman SM, Allinson KSJ, Jaunmuktane Z, Holton JL, Lees AJ, Morris CM, Compta Y, Gelpi E, van Swieten JC, Rajput A, Ferguson L, Cookson MR, Gibbs JR, Blauwendraat C, Ding J, Chia R, Traynor BJ, Pantelyat A, Viollet C, Traynor BJ, Pletnikova O, Troncoso JC, Rosenthal LS, Boxer AL, Respondek G, Arzberger T, Roeber S, Giese A, Burn DJ, Pavese N, Gerhard A, Kobylecki C, Leigh PN, Church A, Hu M (2021) Genetic determinants of survival in progressive supranuclear palsy: a genome-wide association study. Lancet Neurol 20:107\u2013116. https:\/\/doi.org\/10.1016\/S1474-4422(20)30394-X","journal-title":"Lancet Neurol"},{"key":"12314_CR56","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1086\/513320","volume":"80","author":"S Melquist","year":"2007","unstructured":"Melquist S, Craig DW, Huentelman MJ, Crook R, Pearson JV, Baker M, Zismann VL, Gass J, Adamson J, Szelinger S, Corneveaux J, Cannon A, Coon KD, Lincoln S, Adler C, Tuite P, Calne DB, Bigio EH, Uitti RJ, Wszolek ZK, Golbe LI, Caselli RJ, Graff-Radford N, Litvan I, Farrer MJ, Dickson DW, Hutton M, Stephan DA (2007) Identification of a novel risk locus for progressive supranuclear palsy by a pooled genomewide scan of 500,288 single-nucleotide polymorphisms. Am J Human Genetics 80:769\u2013778. https:\/\/doi.org\/10.1086\/513320","journal-title":"Am J Human Genetics"},{"key":"12314_CR57","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1186\/s13024-018-0270-8","volume":"13","author":"JA Chen","year":"2018","unstructured":"Chen JA, Chen Z, Won H, Huang AY, Lowe JK, Wojta K, Yokoyama JS, Bensimon G, Leigh PN, Payan C, Shatunov A, Jones AR, Lewis CM, Deloukas P, Amouyel P, Tzourio C, Dartigues J-F, Ludolph A, Boxer AL, Bronstein JM, Al-Chalabi A, Geschwind DH, Coppola G (2018) Joint genome-wide association study of progressive supranuclear palsy identifies novel susceptibility loci and genetic correlation to neurodegenerative diseases. Mol Neurodegener 13:41. https:\/\/doi.org\/10.1186\/s13024-018-0270-8","journal-title":"Mol Neurodegener"},{"key":"12314_CR58","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1212\/WNL.47.1.1","volume":"4","author":"I Litvan","year":"1996","unstructured":"Litvan I, Agid Y, Calne D, Campbell G, Dubois B, Duvoisin RC, Goetz CG, Golbe LI, Grafman J, Growdon JH, Hallett M, Jankovic J, Quinn NP, Tolosa E, Zee DS (1996) Clinical research criteria for the diagnosis of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome): report of the NINDS-SPSP international workshop. Neurology 4:1\u20139. https:\/\/doi.org\/10.1212\/WNL.47.1.1","journal-title":"Neurology"},{"key":"12314_CR59","doi-asserted-by":"publisher","first-page":"2220","DOI":"10.1111\/ene.15346","volume":"29","author":"B Couto","year":"2022","unstructured":"Couto B, Martinez-Valbuena I, Lee S, Alfradique-Dunham I, Perrin RJ, Perlmutter JS, Cruchaga C, Kim A, Visanji N, Sato C, Rogaeva E, Lang AE, Kovacs GG (2022) Protracted course progressive supranuclear palsy. Eur J Neurol 29:2220\u20132231. https:\/\/doi.org\/10.1111\/ene.15346","journal-title":"Eur J Neurol"},{"key":"12314_CR60","doi-asserted-by":"publisher","first-page":"736","DOI":"10.1016\/S1474-4422(04)00936-6","volume":"3","author":"RK Mahapatra","year":"2004","unstructured":"Mahapatra RK, Edwards MJ, Schott JM, Bhatia KP (2004) Corticobasal degeneration. Lancet Neurol 3:736\u2013743. https:\/\/doi.org\/10.1016\/S1474-4422(04)00936-6","journal-title":"Lancet Neurol"},{"key":"12314_CR61","first-page":"227","volume-title":"Sporadic Tauopathies: Pick\u2019s disease, corticobasal, degeneration progressive supranuclear palsy and argyrophilic grain disease. The neuropathology of Dementia","author":"DW Dickson","year":"2009","unstructured":"Dickson DW (2009) Sporadic Tauopathies: Pick\u2019s disease, corticobasal, degeneration progressive supranuclear palsy and argyrophilic grain disease. The neuropathology of Dementia. Cambridge University Press, pp 227\u2013256"},{"key":"12314_CR62","doi-asserted-by":"publisher","first-page":"II6","DOI":"10.1007\/BF03161076","volume":"246","author":"DW Dickson","year":"1999","unstructured":"Dickson DW (1999) Neuropathologic differentiation of progressive supranuclear palsy and corticobasal degeneration. J Neurol 246:II6\u2013II15. https:\/\/doi.org\/10.1007\/BF03161076","journal-title":"J Neurol"},{"key":"12314_CR63","doi-asserted-by":"crossref","unstructured":"Gibb WRG, Luthert PJ, Marsden CD (1989) Corticobasal degeneration. Brain. http:\/\/brain.oxfordjournals.org\/","DOI":"10.1093\/brain\/112.5.1171"},{"key":"12314_CR64","first-page":"1388","volume":"146","author":"MB Feany","year":"1995","unstructured":"Feany MB, Dickson DW (1995) Widespread cytoskeletal pathology characterizes corticobasal degeneration. Am J Pathol 146:1388","journal-title":"Am J Pathol"},{"key":"12314_CR65","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1111\/neup.12108","volume":"34","author":"T Uchihara","year":"2014","unstructured":"Uchihara T (2014) Pretangles and neurofibrillary changes: similarities and differences between AD and CBD based on molecular and morphological evolution. Neuropathology 34:571\u2013577. https:\/\/doi.org\/10.1111\/neup.12108","journal-title":"Neuropathology"},{"key":"12314_CR66","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1007\/s004010050911","volume":"96","author":"T Komori","year":"1998","unstructured":"Komori T, Arai N, Oda M, Nakayama H, Mori H, Yagishita S, Takahashi T, Amano N, Murayama S, Murakami S, Shibata N, Kobayashi M, Sasaki S, Iwata M (1998) Astrocytic plaques and tufts of abnormal fibers do not coexist in corticobasal degeneration and progressive supranuclear palsy. Acta Neuropathol 96:401\u2013408. https:\/\/doi.org\/10.1007\/s004010050911","journal-title":"Acta Neuropathol"},{"key":"12314_CR67","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1016\/j.parkreldis.2021.09.008","volume":"90","author":"E Leveille","year":"2021","unstructured":"Leveille E, Ross OA, Gan-Or Z (2021) Tau and MAPT genetics in tauopathies and synucleinopathies. Parkinsonism Relat Disord 90:142\u2013154. https:\/\/doi.org\/10.1016\/j.parkreldis.2021.09.008","journal-title":"Parkinsonism Relat Disord"},{"key":"12314_CR68","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/j.ajhg.2010.01.007","volume":"86","author":"MP Donnelly","year":"2010","unstructured":"Donnelly MP, Paschou P, Grigorenko E, Gurwitz D, Mehdi SQ, Kajuna SLB, Barta C, Kungulilo S, Karoma NJ, Lu R-B, Zhukova OV, Kim J-J, Comas D, Siniscalco M, New M, Li P, Li H, Manolopoulos VG, Speed WC, Rajeevan H, Pakstis AJ, Kidd JR, Kidd KK (2010) The distribution and most recent common ancestor of the 17q21 inversion in humans. Am J Human Genetics 86:161\u2013171. https:\/\/doi.org\/10.1016\/j.ajhg.2010.01.007","journal-title":"Am J Human Genetics"},{"key":"12314_CR69","doi-asserted-by":"publisher","first-page":"983","DOI":"10.1002\/alz.12099","volume":"16","author":"SL Strickland","year":"2020","unstructured":"Strickland SL, Reddy JS, Allen M, N\u2019songo A, Burgess JD, Corda MM, Ballard T, Wang X, Carrasquillo MM, Biernacka JM, Jenkins GD, Mukherjee S, Boehme K, Crane P, Kauwe JS, Ertekin-Taner N (2020) MAPT haplotype-stratified GWAS reveals differential association for AD risk variants. Alzheimer\u2019s Dementia 16:983\u20131002. https:\/\/doi.org\/10.1002\/alz.12099","journal-title":"Alzheimer\u2019s Dementia"},{"key":"12314_CR70","doi-asserted-by":"publisher","first-page":"710","DOI":"10.1001\/jamaneurol.2019.0250","volume":"76","author":"MG Heckman","year":"2019","unstructured":"Heckman MG, Brennan RR, Labb\u00e9 C, Soto AI, Koga S, DeTure MA, Murray ME, Petersen RC, Boeve BF, van Gerpen JA, Uitti RJ, Wszolek ZK, Rademakers R, Dickson DW, Ross OA (2019) Association of MAPT subhaplotypes with risk of progressive supranuclear palsy and severity of tau pathology. JAMA Neurol 76:710. https:\/\/doi.org\/10.1001\/jamaneurol.2019.0250","journal-title":"JAMA Neurol"},{"key":"12314_CR71","doi-asserted-by":"publisher","first-page":"637","DOI":"10.3233\/JAD-190906","volume":"74","author":"L Miguel","year":"2020","unstructured":"Miguel L, Frebourg T, Campion D, Lecourtois M (2020) Moderate overexpression of tau in drosophila exacerbates amyloid-\u03b2-induced neuronal phenotypes and correlates with tau oligomerization. J Alzheimer\u2019s Dis 74:637\u2013647. https:\/\/doi.org\/10.3233\/JAD-190906","journal-title":"J Alzheimer\u2019s Dis"},{"key":"12314_CR72","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1038\/s41586-020-2043-0","volume":"580","author":"W Zhang","year":"2020","unstructured":"Zhang W, Tarutani A, Newell KL, Murzin AG, Matsubara T, Falcon B, Vidal R, Garringer HJ, Shi Y, Ikeuchi T, Murayama S, Ghetti B, Hasegawa M, Goedert M, Scheres SHW (2020) Novel tau filament fold in corticobasal degeneration. Nature 580:283\u2013287. https:\/\/doi.org\/10.1038\/s41586-020-2043-0","journal-title":"Nature"},{"key":"12314_CR73","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1038\/ejhg.2008.185","volume":"17","author":"E Canu","year":"2009","unstructured":"Canu E, Boccardi M, Ghidoni R, Benussi L, Testa C, Pievani M, Bonetti M, Binetti G, Frisoni GB (2009) H1 haplotype of the MAPT gene is associated with lower regional gray matter volume in healthy carriers. Eur J Hum Genet 17:287\u2013294. https:\/\/doi.org\/10.1038\/ejhg.2008.185","journal-title":"Eur J Hum Genet"},{"key":"12314_CR74","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1038\/s41586-018-0454-y","volume":"561","author":"B Falcon","year":"2018","unstructured":"Falcon B, Zhang W, Murzin AG, Murshudov G, Garringer HJ, Vidal R, Crowther RA, Ghetti B, Scheres SHW, Goedert M (2018) Structures of filaments from Pick\u2019s disease reveal a novel tau protein fold. Nature 561:137\u2013140. https:\/\/doi.org\/10.1038\/s41586-018-0454-y","journal-title":"Nature"},{"key":"12314_CR75","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1111\/neup.12394","volume":"37","author":"C Ikeda","year":"2017","unstructured":"Ikeda C, Yokota O, Miki T, Takenoshita S, Ishizu H, Mori Y, Yamazaki K, Ozaki Y, Ueno S-I, Ishihara T, Hasegawa M, Terada S, Yamada N (2017) Pick\u2019s disease with neuronal four-repeat tau accumulation in the basal ganglia, brain stem nuclei and cerebellum. Neuropathology 37:544\u2013559. https:\/\/doi.org\/10.1111\/neup.12394","journal-title":"Neuropathology"},{"key":"12314_CR76","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1111\/j.1750-3639.1998.tb00158.x","volume":"8","author":"DW Dickson","year":"1998","unstructured":"Dickson DW (1998) Pick\u2019s disease: a modern approach. Brain Pathol 8:339\u2013354. https:\/\/doi.org\/10.1111\/j.1750-3639.1998.tb00158.x","journal-title":"Brain Pathol"},{"key":"12314_CR77","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2022.944806","author":"N Olfati","year":"2022","unstructured":"Olfati N, Shoeibi A, Litvan I (2022) Clinical spectrum of tauopathies. Front Neurol. https:\/\/doi.org\/10.3389\/fneur.2022.944806","journal-title":"Front Neurol"},{"key":"12314_CR78","doi-asserted-by":"publisher","first-page":"1141","DOI":"10.1212\/WNL.33.9.1141","volume":"33","author":"R Lilly","year":"1983","unstructured":"Lilly R, Cummings JL, Benson DF, Frankel M (1983) The human Kl\u00fcver-Bucy syndrome. Neurology 33:1141\u20131141. https:\/\/doi.org\/10.1212\/WNL.33.9.1141","journal-title":"Neurology"},{"key":"12314_CR79","doi-asserted-by":"publisher","first-page":"2645","DOI":"10.1093\/brain\/awh591","volume":"128","author":"IF Bronner","year":"2005","unstructured":"Bronner IF, Ter Meulen BC, Azmani A, Severijnen LA, Willemsen R, Kamphorst W, Ravid R, Heutink P, Van Swieten JC (2005) Hereditary Pick\u2019s disease with the G272V tau mutation shows predominant three-repeat tau pathology. Brain 128:2645\u20132653. https:\/\/doi.org\/10.1093\/brain\/awh591","journal-title":"Brain"},{"key":"12314_CR80","doi-asserted-by":"publisher","DOI":"10.1007\/s00401-023-02598-6","author":"M Schweighauser","year":"2023","unstructured":"Schweighauser M, Garringer HJ, Klingstedt T, Nilsson KPR, Masuda-Suzukake M, Murrell JR, Risacher SL, Vidal R, Scheres SHW, Goedert M, Ghetti B, Newell KL (2023) Mutation \u2206K281 in MAPT causes Pick\u2019s disease. Acta Neuropathol. https:\/\/doi.org\/10.1007\/s00401-023-02598-6","journal-title":"Acta Neuropathol"},{"key":"12314_CR81","doi-asserted-by":"publisher","first-page":"13","DOI":"10.3389\/fnmol.2020.569395","volume":"8","author":"G Siano","year":"2020","unstructured":"Siano G, Micaelli M, Scarlatti A, Quercioli V, Di Primio C, Cattaneo A (2020) The Q336H MAPT mutation linked to Pick\u2019s disease leads to increased binding of tau to the microtubule network via altered conformational and phosphorylation effects. Front Mol Neurosci 8:13. https:\/\/doi.org\/10.3389\/fnmol.2020.569395","journal-title":"Front Mol Neurosci"},{"key":"12314_CR82","doi-asserted-by":"publisher","unstructured":"Valentino RR, Scotton Mbioch WJ, Roemer SF, Lashley T, Heckman MG, Shoai M, Martinez-Carrasco A, Tamvaka N, Walton RL, Baker MC, Macpherson HL, Real R, Soto-Beasley AI, Mok K, Revesz T, Warner TT, Jaunmuktane Z, Boeve BF, Christopher E.A., Deture M, Duara R, Graff-Radford NR, Josephs KA, Knopman DS, Koga S, Murray ME, Lyons KE, Pahwa R, Parisi JE, Petersen RC, Whitwell J, Grinberg LT, Miller B, Schlereth A, Seeley WW, Spina S, Grossman M, Irwin DJ, Lee EB, Suh E, Trojanowski JQ, Van Deerlin VM, Wolk DA, Connors TR, Dooley PM, Frosch MP, Oakley DH, Aldecoa I, Balasa M, Gelpi E, Borrego-\u00c9cija S, Maria de Eugenio Hu\u00e9lamo R, Gascon-Bayarri J, S\u00e1nchez-Valle R, Sanz-Cartagena P, Pi\u00f1ol-Ripoll G, Molina-Porcel L, Bigio EH, Flanagan ME, Gefen T, Rogalski EJ, Weintraub S, Redding-Ochoa J, Chang K, Troncoso JC, Prokop S, Newell KL, Ghetti B, Jones M, Richardson A, Robinson AC, Roncaroli F, Snowden J, Allinson K, Green O, Rowe JB, Singh P, Beach TG, Serrano GE, Flowers XE, Goldman JE, Heaps AC, Leskinen SP, Teich AF, Black SE, Keith JL, Masellis M, Bodi I, King A, Sarraj S-A (2023) Creating the Pick\u2019s disease international consortium: association study of MAPT H2 haplotype with risk of Pick\u2019s disease. medRxiv. https:\/\/doi.org\/10.1101\/2023.04.17.23288471.","DOI":"10.1101\/2023.04.17.23288471"},{"key":"12314_CR83","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1002\/ana.20083","volume":"55","author":"B Dermaut","year":"2004","unstructured":"Dermaut B, Kumar-Singh S, Engelborghs S, Theuns J, Rademakers R, Saerens J, Pickut BA, Peeters K, Van Den Broeck M, Vennekens K, Claes S, Cruts M, Cras P, Martin J-J, Van Broeckhoven C, De Deyn PP (2004) A novel presenilin 1 mutation associated with Pick\u2019s disease but not\u202f?-Amyloid plaques. Ann Neurol 55:617\u2013626. https:\/\/doi.org\/10.1002\/ana.20083","journal-title":"Ann Neurol"},{"key":"12314_CR84","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1002\/ana.1223","volume":"50","author":"M Neumann","year":"2001","unstructured":"Neumann M, Schulz-Schaeffer W, Anthony Crowther R, Smith MJ, Spillantini MG, Goedert M, Kretzschmar HA (2001) Pick\u2019s disease associated with the novel tau gene mutation K369I. Ann Neurol 50:503\u2013513. https:\/\/doi.org\/10.1002\/ana.1223","journal-title":"Ann Neurol"},{"key":"12314_CR85","doi-asserted-by":"publisher","first-page":"1042","DOI":"10.1097\/NEN.0000000000000248","volume":"74","author":"P Tacik","year":"2015","unstructured":"Tacik P, DeTure M, Hinkle KM, Lin WL, Sanchez-Contreras M, Carlomagno Y, Pedraza O, Rademakers R, Ross OA, Wszolek ZK, Dickson DW (2015) A Novel tau mutation in exon 12, P. Q336H, causes hereditary pick disease. J Neuropathol Exp Neurol 74:1042\u20131052. https:\/\/doi.org\/10.1097\/NEN.0000000000000248","journal-title":"J Neuropathol Exp Neurol"},{"key":"12314_CR86","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1186\/s40035-023-00352-2","volume":"12","author":"K Yoshida","year":"2023","unstructured":"Yoshida K, Hata Y, Ichimata S, Okada K, Nishida N (2023) Argyrophilic grain disease is common in older adults and may be a risk factor for suicide: a study of japanese forensic autopsy cases. Transl Neurodegener 12:16. https:\/\/doi.org\/10.1186\/s40035-023-00352-2","journal-title":"Transl Neurodegener"},{"key":"12314_CR87","doi-asserted-by":"publisher","first-page":"1109","DOI":"10.3233\/JAD-171115","volume":"63","author":"MJ Gil","year":"2018","unstructured":"Gil MJ, Manzano MS, Cuadrado ML, Fern\u00e1ndez C, G\u00f3m\u00e9z E, Matesanz C, Calero M, R\u00e1bano A (2018) Argyrophilic grain pathology in frontotemporal lobar degeneration: demographic, clinical, neuropathological, and genetic features. J Alzheimer\u2019s Dis 63:1109\u20131117. https:\/\/doi.org\/10.3233\/JAD-171115","journal-title":"J Alzheimer\u2019s Dis"},{"key":"12314_CR88","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1007\/s00401-007-0322-6","volume":"116","author":"G Kovacs","year":"2008","unstructured":"Kovacs G, Pittman A, Revesz T, Luk C, Lees A, Kiss E, Tariska P, Laszlo L, Moln\u00e1r K, Molnar MJ, Tolnay M, de Silva R (2008) MAPT S305I mutation: implications for argyrophilic grain disease. Acta Neuropathol 116:103\u2013118. https:\/\/doi.org\/10.1007\/s00401-007-0322-6","journal-title":"Acta Neuropathol"},{"key":"12314_CR89","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1007\/s00401-013-1229-z","volume":"127","author":"A R\u00f6nnb\u00e4ck","year":"2014","unstructured":"R\u00f6nnb\u00e4ck A, Nennesmo I, Tuominen H, Grueninger F, Viitanen M, Graff C (2014) Neuropathological characterization of two siblings carrying the MAPT S305S mutation demonstrates features resembling argyrophilic grain disease. Acta Neuropathol 127:297\u2013298. https:\/\/doi.org\/10.1007\/s00401-013-1229-z","journal-title":"Acta Neuropathol"},{"key":"12314_CR90","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1590\/S1415-47572013000400006","volume":"36","author":"D Villela","year":"2013","unstructured":"Villela D, Kimura L, Schlesinger D, Gon\u00e7alves A, Pearson PL, Suemoto CK, Pasqualucci C, Krepischi AC, Grinbergand LT, Rosenberg C (2013) Germline DNA copy number variation in individuals with argyrophilic grain disease reveals CTNS as a plausible candidate gene. Genet Mol Biol 36:498\u2013501. https:\/\/doi.org\/10.1590\/S1415-47572013000400006","journal-title":"Genet Mol Biol"},{"key":"12314_CR91","doi-asserted-by":"publisher","first-page":"277","DOI":"10.5114\/fn.2018.80859","volume":"56","author":"S Das","year":"2018","unstructured":"Das S, Ishaque A (2018) Argyrophilic grain disease: a clinicopathological review of an overlooked tauopathy. Folia Neuropathol 56:277\u2013283. https:\/\/doi.org\/10.5114\/fn.2018.80859","journal-title":"Folia Neuropathol"},{"key":"12314_CR92","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1093\/jnen\/61.6.547","volume":"61","author":"T Togo","year":"2002","unstructured":"Togo T, Sahara N, Yen S-H, Cookson N, Ishizawa T, Hutton M, de Silva R, Lees A, Dickson DW (2002) Argyrophilic grain disease is a sporadic 4-repeat tauopathy. J Neuropathol Exp Neurol 61:547\u2013556. https:\/\/doi.org\/10.1093\/jnen\/61.6.547","journal-title":"J Neuropathol Exp Neurol"},{"key":"12314_CR93","doi-asserted-by":"publisher","DOI":"10.1016\/j.arr.2023.101916","volume":"87","author":"I Ferrer","year":"2023","unstructured":"Ferrer I (2023) The unique neuropathological vulnerability of the human brain to aging. Ageing Res Rev 87:101916. https:\/\/doi.org\/10.1016\/j.arr.2023.101916","journal-title":"Ageing Res Rev"},{"key":"12314_CR94","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1212\/CON.0000000000000697","volume":"25","author":"GA Jicha","year":"2019","unstructured":"Jicha GA, Nelson PT (2019) Hippocampal sclerosis, argyrophilic grain disease, and primary age-related tauopathy. CONTINUUM Lifelong Learning in Neurology 25:208\u2013233. https:\/\/doi.org\/10.1212\/CON.0000000000000697","journal-title":"CONTINUUM Lifelong Learning in Neurology"},{"key":"12314_CR95","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-pathmechdis","author":"J G\u00f6tz","year":"2018","unstructured":"G\u00f6tz J, Halliday G, Nisbet RM (2018) Molecular pathogenesis of the tauopathies. Annu Rev Pathol Mech Dis. https:\/\/doi.org\/10.1146\/annurev-pathmechdis","journal-title":"Annu Rev Pathol Mech Dis"},{"key":"12314_CR96","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1111\/ene.15603","volume":"30","author":"M Buciuc","year":"2023","unstructured":"Buciuc M, Koga S, Pham NTT, Duffy JR, Knopman DS, Ali F, Boeve BF, Graff-Radford J, Botha H, Lowe VJ, Nguyen A, Reichard RR, Dickson DW, Petersen RC, Whitwell JL, Josephs KA (2023) The many faces of globular glial tauopathy: a clinical and imaging study. Eur J Neurol 30:321\u2013333. https:\/\/doi.org\/10.1111\/ene.15603","journal-title":"Eur J Neurol"},{"key":"12314_CR97","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1007\/s00401-015-1425-0","volume":"130","author":"P Tacik","year":"2015","unstructured":"Tacik P, DeTure M, Lin WL, Sanchez Contreras M, Wojtas A, Hinkle KM, Fujioka S, Baker MC, Walton RL, Carlomagno Y, Brown PH, Strongosky AJ, Kouri N, Murray ME, Petrucelli L, Josephs KA, Rademakers R, Ross OA, Wszolek ZK, Dickson DW (2015) A novel tau mutation, p. K317N, causes globular glial tauopathy. Acta Neuropathol 130:199\u2013214. https:\/\/doi.org\/10.1007\/s00401-015-1425-0","journal-title":"Acta Neuropathol"},{"key":"12314_CR98","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1111\/nan.12367","volume":"43","author":"P Tacik","year":"2017","unstructured":"Tacik P, Sanchez-Contreras M, DeTure M, Murray ME, Rademakers R, Ross OA, Wszolek ZK, Parisi JE, Knopman DS, Petersen RC, Dickson DW (2017) Clinicopathologic heterogeneity in frontotemporal dementia and parkinsonism linked to chromosome 17 (FTDP-17) due to microtubule-associated protein tau (MAPT) p. P301L mutation, including a patient with globular glial tauopathy. Neuropathol Appl Neurobiol 43:200\u2013214. https:\/\/doi.org\/10.1111\/nan.12367","journal-title":"Neuropathol Appl Neurobiol"},{"key":"12314_CR99","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1093\/jnen\/nlx007","volume":"76","author":"G Kovacs","year":"2017","unstructured":"Kovacs G, Robinson JL, Xie SX, Lee EB, Grossman M, Wolk DA, Irwin DJ, Weintraub D, Kim CF, Schuck T, Yousef A, Wagner ST, Suh E, Van Deerlin VM, Lee VM-Y, Trojanowski JQ (2017) Evaluating the patterns of aging-related tau astrogliopathy unravels novel insights into brain aging and neurodegenerative diseases. J Neuropathol Exp Neurol 76:270\u2013288. https:\/\/doi.org\/10.1093\/jnen\/nlx007","journal-title":"J Neuropathol Exp Neurol"},{"key":"12314_CR100","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1007\/s00401-014-1349-0","volume":"128","author":"JF Crary","year":"2014","unstructured":"Crary JF, Trojanowski JQ, Schneider JA, Abisambra JF, Abner EL, Alafuzoff I, Arnold SE, Attems J, Beach TG, Bigio EH, Cairns NJ, Dickson DW, Gearing M, Grinberg LT, Hof PR, Hyman BT, Jellinger K, Jicha GA, Kovacs GG, Knopman DS, Kofler J, Kukull WA, Mackenzie IR, Masliah E, McKee A, Montine TJ, Murray ME, Neltner JH, Santa-Maria I, Seeley WW, Serrano-Pozo A, Shelanski ML, Stein T, Takao M, Thal DR, Toledo JB, Troncoso JC, Vonsattel JP, White CL, Wisniewski T, Woltjer RL, Yamada M, Nelson PT (2014) Primary age-related tauopathy (PART): a common pathology associated with human aging. Acta Neuropathol 128:755\u2013766. https:\/\/doi.org\/10.1007\/s00401-014-1349-0","journal-title":"Acta Neuropathol"},{"key":"12314_CR101","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1007\/s00401-006-0048-x","volume":"111","author":"R de Silva","year":"2006","unstructured":"de Silva R, Lashley T, Strand C, Shiarli A-M, Shi J, Tian J, Bailey KL, Davies P, Bigio EH, Arima K, Iseki E, Murayama S, Kretzschmar H, Neumann M, Lippa C, Halliday G, MacKenzie J, Ravid R, Dickson D, Wszolek Z, Iwatsubo T, Pickering-Brown SM, Holton J, Lees A, Revesz T, Mann DMA (2006) An immunohistochemical study of cases of sporadic and inherited frontotemporal lobar degeneration using 3R- and 4R-specific tau monoclonal antibodies. Acta Neuropathol 111:329\u2013340. https:\/\/doi.org\/10.1007\/s00401-006-0048-x","journal-title":"Acta Neuropathol"},{"key":"12314_CR102","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1186\/s40478-021-01233-3","volume":"9","author":"MA Iida","year":"2021","unstructured":"Iida MA, Farrell K, Walker JM, Richardson TE, Marx GA, Bryce CH, Purohit D, Ayalon G, Beach TG, Bigio EH, Cortes EP, Gearing M, Haroutunian V, McMillan CT, Lee EB, Dickson DW, McKee AC, Stein TD, Trojanowski JQ, Woltjer RL, Kovacs GG, Kofler JK, Kaye J, White CL, Crary JF (2021) Predictors of cognitive impairment in primary age-related tauopathy: an autopsy study. Acta Neuropathol Commun 9:134. https:\/\/doi.org\/10.1186\/s40478-021-01233-3","journal-title":"Acta Neuropathol Commun"},{"key":"12314_CR103","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1007\/s00401-012-1017-1","volume":"124","author":"I Santa-Maria","year":"2012","unstructured":"Santa-Maria I, Haggiagi A, Liu X, Wasserscheid J, Nelson PT, Dewar K, Clark LN, Crary JF (2012) The MAPT H1 haplotype is associated with tangle-predominant dementia. Acta Neuropathol 124:693\u2013704. https:\/\/doi.org\/10.1007\/s00401-012-1017-1","journal-title":"Acta Neuropathol"},{"key":"12314_CR104","doi-asserted-by":"publisher","first-page":"53","DOI":"10.29245\/2572.942X\/2016\/6.1059","volume":"1","author":"J Crary","year":"2016","unstructured":"Crary J (2016) Primary age-related tauopathy and the amyloid cascade hypothesis: the exception that proves the rule? J Neurol Neuromed 1:53\u201357. https:\/\/doi.org\/10.29245\/2572.942X\/2016\/6.1059","journal-title":"J Neurol Neuromed"},{"key":"12314_CR105","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1111\/nan.12427","volume":"44","author":"G Kovacs","year":"2018","unstructured":"Kovacs G, Yousef A, Kaindl S, Lee VM, Trojanowski JQ (2018) Connexin-43 and aquaporin-4 are markers of ageing-related tau astrogliopathy (ARTAG)-related astroglial response. Neuropathol Appl Neurobiol 44:491\u2013505. https:\/\/doi.org\/10.1111\/nan.12427","journal-title":"Neuropathol Appl Neurobiol"},{"key":"12314_CR106","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1590\/S1980-57642015DN91000002","volume":"9","author":"RD Rodriguez","year":"2015","unstructured":"Rodriguez RD, Grinberg LT (2015) Argyrophilic grain disease: an underestimated tauopathy. Dementia Neuropsychol 9:2\u20138. https:\/\/doi.org\/10.1590\/S1980-57642015DN91000002","journal-title":"Dementia Neuropsychol"},{"key":"12314_CR107","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1212\/WNL.0b013e31827f0fd1","volume":"80","author":"MJ Armstrong","year":"2013","unstructured":"Armstrong MJ, Litvan I, Lang AE, Bak TH, Bhatia KP, Borroni B, Boxer AL, Dickson DW, Grossman M, Hallett M, Josephs KA, Kertesz A, Lee SE, Miller BL, Reich SG, Riley DE, Tolosa E, Troster AI, Vidailhet M, Weiner WJ (2013) Criteria for the diagnosis of corticobasal degeneration. Neurology 80:496\u2013503. https:\/\/doi.org\/10.1212\/WNL.0b013e31827f0fd1","journal-title":"Neurology"},{"key":"12314_CR108","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1590\/S1980-57642013DN70100004","volume":"7","author":"VS Bahia","year":"2013","unstructured":"Bahia VS, Takada LT, Deramecourt V (2013) Neuropathology of frontotemporal lobar degeneration: a review. Dementia Neuropsychol 7:19\u201326. https:\/\/doi.org\/10.1590\/S1980-57642013DN70100004","journal-title":"Dementia Neuropsychol"},{"key":"12314_CR109","doi-asserted-by":"publisher","first-page":"742","DOI":"10.1021\/acs.biochem.8b01039","volume":"58","author":"Y Mutreja","year":"2019","unstructured":"Mutreja Y, Combs B, Gamblin TC (2019) FTDP-17 mutations alter the aggregation and microtubule stabilization propensity of tau in an isoform-specific fashion. Biochemistry 58:742\u2013754. https:\/\/doi.org\/10.1021\/acs.biochem.8b01039","journal-title":"Biochemistry"},{"key":"12314_CR110","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1001\/jamaneurol.2013.5100","volume":"71","author":"P Caroppo","year":"2014","unstructured":"Caroppo P, Le Ber I, Clot F, Rivaud-P\u00e9choux S, Camuzat A, De Septenville A, Boutoleau-Bretonni\u00e8re C, Mourlon V, Sauv\u00e9e M, Lebouvier T, Bonnet A-M, Levy R, Vercelletto M, Brice A (2014) DCTN1 mutation analysis in families with progressive supranuclear palsy-like phenotypes. JAMA Neurol 71:208. https:\/\/doi.org\/10.1001\/jamaneurol.2013.5100","journal-title":"JAMA Neurol"},{"key":"12314_CR111","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1002\/mds.29322","volume":"38","author":"N Olfati","year":"2023","unstructured":"Olfati N, Ghodsi H, Bayram E, Litvan I (2023) Why therapeutic trials fail in primary tauopathies. Mov Disord 38:545\u2013550. https:\/\/doi.org\/10.1002\/mds.29322","journal-title":"Mov Disord"},{"key":"12314_CR112","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1016\/0165-6147(91)90609-V","volume":"12","author":"J Hardy","year":"1991","unstructured":"Hardy J, Allsop D (1991) Amyloid deposition as the central event in the aetiology of Alzheimer\u2019s disease. Trends Pharmacol Sci 12:383\u2013388. https:\/\/doi.org\/10.1016\/0165-6147(91)90609-V","journal-title":"Trends Pharmacol Sci"},{"key":"12314_CR113","doi-asserted-by":"publisher","first-page":"704","DOI":"10.1038\/349704a0","volume":"349","author":"A Goate","year":"1991","unstructured":"Goate A, Chartier-Harlin M-C, Mullan M, Brown J, Crawford F, Fidani L, Giuffra L, Haynes A, Irving N, James L, Mant R, Newton P, Rooke K, Roques P, Talbot C, Pericak-Vance M, Roses A, Williamson R, Rossor M, Owen M, Hardy J (1991) Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer\u2019s disease. Nature 349:704\u2013706. https:\/\/doi.org\/10.1038\/349704a0","journal-title":"Nature"},{"key":"12314_CR114","doi-asserted-by":"publisher","first-page":"864","DOI":"10.1038\/nm0896-864","volume":"2","author":"D Scheuner","year":"1996","unstructured":"Scheuner D, Eckman C, Jensen M, Song X, Citron M, Suzuki N, Bird TD, Hardy J, Hutton M, Kukull W, Larson E, Levy-Lahad L, Viitanen M, Peskind E, Poorkaj P, Schellenberg G, Tanzi R, Wasco W, Lannfelt L, Selkoe D, Younkin S (1996) Secreted amyloid \u03b2\u2013protein similar to that in the senile plaques of Alzheimer\u2019s disease is increased in vivo by the presenilin 1 and 2 and APP mutations linked to familial Alzheimer\u2019s disease. Nat Med 2:864\u2013870. https:\/\/doi.org\/10.1038\/nm0896-864","journal-title":"Nat Med"},{"key":"12314_CR115","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1126\/science.1072994","volume":"297","author":"J Hardy","year":"2002","unstructured":"Hardy J, Selkoe DJ (2002) The amyloid hypothesis of Alzheimer\u2019s disease: progress and problems on the road to therapeutics. Science 297:353\u2013356. https:\/\/doi.org\/10.1126\/science.1072994","journal-title":"Science"},{"key":"12314_CR116","doi-asserted-by":"publisher","first-page":"437","DOI":"10.2174\/156720506779025242","volume":"3","author":"M Blurton-Jones","year":"2006","unstructured":"Blurton-Jones M, LaFerla F (2006) Pathways by which A\u03b2 facilitates tau pathology. Curr Alzheimer Res 3:437\u2013448. https:\/\/doi.org\/10.2174\/156720506779025242","journal-title":"Curr Alzheimer Res"},{"key":"12314_CR117","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1002\/alz.12192","volume":"17","author":"AFT Arnsten","year":"2021","unstructured":"Arnsten AFT, Datta D, Del Tredici K, Braak H (2021) Hypothesis: tau pathology is an initiating factor in sporadic Alzheimer\u2019s disease. Alzheimer\u2019s Dementia 17:115\u2013124. https:\/\/doi.org\/10.1002\/alz.12192","journal-title":"Alzheimer\u2019s Dementia"},{"key":"12314_CR118","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1016\/0166-2236(93)90078-Z","volume":"16","author":"M Goedert","year":"1993","unstructured":"Goedert M (1993) Tau protein and the neurofibrillary pathology of Alzheimer\u2019s disease. Trends Neurosci 16:460\u2013465. https:\/\/doi.org\/10.1016\/0166-2236(93)90078-Z","journal-title":"Trends Neurosci"},{"key":"12314_CR119","doi-asserted-by":"publisher","first-page":"680","DOI":"10.1016\/j.jalz.2017.11.005","volume":"14","author":"CD Paspalas","year":"2018","unstructured":"Paspalas CD, Carlyle BC, Leslie S, Preuss TM, Crimins JL, Huttner AJ, van Dyck CH, Rosene DL, Nairn AC, Arnsten AFT (2018) The aged rhesus macaque manifests Braak stage III\/IV Alzheimer\u2019s-like pathology. Alzheimer\u2019s Dementia 14:680\u2013691. https:\/\/doi.org\/10.1016\/j.jalz.2017.11.005","journal-title":"Alzheimer\u2019s Dementia"},{"key":"12314_CR120","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1038\/s41392-023-01484-7","volume":"8","author":"Y Zhang","year":"2023","unstructured":"Zhang Y, Chen H, Li R, Sterling K, Song W (2023) Amyloid \u03b2-based therapy for Alzheimer\u2019s disease: challenges, successes and future. Signal Transduct Target Ther 8:248. https:\/\/doi.org\/10.1038\/s41392-023-01484-7","journal-title":"Signal Transduct Target Ther"},{"key":"12314_CR121","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1016\/j.trci.2018.06.014","volume":"4","author":"JW Kinney","year":"2018","unstructured":"Kinney JW, Bemiller SM, Murtishaw AS, Leisgang AM, Salazar AM, Lamb BT (2018) Inflammation as a central mechanism in Alzheimer\u2019s disease. Alzheimer\u2019s Dementia Transl Res Clin Interv 4:575\u2013590. https:\/\/doi.org\/10.1016\/j.trci.2018.06.014","journal-title":"Alzheimer\u2019s Dementia Transl Res Clin Interv"},{"key":"12314_CR122","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/B978-0-444-63639-3.00010-4","volume":"150","author":"I Alafuzoff","year":"2018","unstructured":"Alafuzoff I (2018) Minimal neuropathologic diagnosis for brain banking in the normal middle-aged and aged brain and in neurodegenerative disorders. Handbook Clin Neurol 150:131\u2013141. https:\/\/doi.org\/10.1016\/B978-0-444-63639-3.00010-4","journal-title":"Handbook Clin Neurol"},{"key":"12314_CR123","doi-asserted-by":"publisher","unstructured":"Kyalu Ngoie ZN, Balty C, Pyr dit Ruys S, Vanparys AAT, Huyghe NDG, Herinckx G, Johanns M, Boyer E, Kienlen-Campard P, Rider MH, Vertommen D, Hanseeuw BJ (2023) Specific post-translational modifications of soluble tau protein distinguishes Alzheimer\u2019s disease and primary tauopathies. Nat Commun14:3706. https:\/\/doi.org\/10.1038\/s41467-023-39328-1","DOI":"10.1038\/s41467-023-39328-1"},{"key":"12314_CR124","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1038\/s41588-022-01024-z","volume":"54","author":"C Bellenguez","year":"2022","unstructured":"Bellenguez C, K\u00fc\u00e7\u00fckali F, Jansen IE, Kleineidam L, Moreno-Grau S, Amin N, Naj AC, Campos-Martin R, Grenier-Boley B, Andrade V, Holmans PA, Boland A, Damotte V, van der Lee SJ, Costa MR, Kuulasmaa T, Yang Q, de Rojas I, Bis JC, Yaqub A, Prokic I, Chapuis J, Ahmad S, Giedraitis V, Aarsland D, Garcia-Gonzalez P, Abdelnour C, Alarc\u00f3n-Mart\u00edn E, Alcolea D, Alegret M, Alvarez I, \u00c1lvarez V, Armstrong NJ, Tsolaki A, Ant\u00fanez C, Appollonio I, Arcaro M, Archetti S, Pastor AA, Arosio B, Athanasiu L, Bailly H, Banaj N, Baquero M, Barral S, Beiser A, Pastor AB, Below JE, Benchek P, Benussi L, Berr C, Besse C, Bessi V, Binetti G, Bizarro A, Blesa R, Boada M, Boerwinkle E, Borroni B, Boschi S, Boss\u00f9 P, Br\u00e5then G, Bressler J, Bresner C, Brodaty H, Brookes KJ, Brusco LI, Buiza-Rueda D, B\u00fbrger K, Burholt V, Bush WS, Calero M, Cantwell LB, Chene G, Chung J, Cuccaro ML, Carracedo \u00c1, Cecchetti R, Cervera-Carles L, Charbonnier C, Chen H-H, Chillotti C, Ciccone S, Claassen JAHR, Clark C, Conti E, Corma-G\u00f3mez A, Costantini E, Custodero C, Daian D, Dalmasso MC, Daniele A, Dardiotis E, Dartigues J-F, de Deyn PP, de Paiva Lopes K, de Witte LD, Debette S et al (2022) New insights into the genetic etiology of Alzheimer\u2019s disease and related dementias. Nat Genet 54:412\u2013436. https:\/\/doi.org\/10.1038\/s41588-022-01024-z","journal-title":"Nat Genet"},{"key":"12314_CR125","doi-asserted-by":"publisher","first-page":"104511","DOI":"10.1016\/j.ebiom.2023.104511","volume":"90","author":"SJ Andrews","year":"2023","unstructured":"Andrews SJ, Renton AE, Fulton-Howard B, Podlesny-Drabiniok A, Marcora E, Goate AM (2023) The complex genetic architecture of Alzheimer\u2019s disease: novel insights and future directions. EBioMedicine 90:104511. https:\/\/doi.org\/10.1016\/j.ebiom.2023.104511","journal-title":"EBioMedicine"},{"key":"12314_CR126","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1038\/s43587-023-00368-3","volume":"3","author":"N Koutsodendris","year":"2023","unstructured":"Koutsodendris N, Blumenfeld J, Agrawal A, Traglia M, Grone B, Zilberter M, Yip O, Rao A, Nelson MR, Hao Y, Thomas R, Yoon SY, Arriola P, Huang Y (2023) Neuronal APOE4 removal protects against tau-mediated gliosis, neurodegeneration and myelin deficits. Nature Aging 3:275\u2013296. https:\/\/doi.org\/10.1038\/s43587-023-00368-3","journal-title":"Nature Aging"},{"key":"12314_CR127","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1007\/s00401-015-1415-2","volume":"129","author":"M Takahashi","year":"2015","unstructured":"Takahashi M, Miyata H, Kametani F, Nonaka T, Akiyama H, Hisanaga S, Hasegawa M (2015) Extracellular association of APP and tau fibrils induces intracellular aggregate formation of tau. Acta Neuropathol 129:895\u2013907. https:\/\/doi.org\/10.1007\/s00401-015-1415-2","journal-title":"Acta Neuropathol"},{"key":"12314_CR128","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1186\/s40478-021-01259-7","volume":"9","author":"CM Soto-Fagu\u00e1s","year":"2021","unstructured":"Soto-Fagu\u00e1s CM, Sanchez-Molina P, Saura CA (2021) Loss of presenilin function enhances tau phosphorylation and aggregation in mice. Acta Neuropathol Commun 9:162. https:\/\/doi.org\/10.1186\/s40478-021-01259-7","journal-title":"Acta Neuropathol Commun"},{"key":"12314_CR129","doi-asserted-by":"publisher","first-page":"17662","DOI":"10.1038\/s41598-023-44378-y","volume":"13","author":"M Lundberg","year":"2023","unstructured":"Lundberg M, Sng LMF, Szul P, Dunne R, Bayat A, Burnham SC, Bauer DC, Twine NA (2023) Novel Alzheimer\u2019s disease genes and epistasis identified using machine learning GWAS platform. Sci Rep 13:17662. https:\/\/doi.org\/10.1038\/s41598-023-44378-y","journal-title":"Sci Rep"},{"key":"12314_CR130","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1186\/s13024-021-00452-5","volume":"16","author":"M Seto","year":"2021","unstructured":"Seto M, Weiner RL, Dumitrescu L, Hohman TJ (2021) Protective genes and pathways in Alzheimer\u2019s disease: moving towards precision interventions. Mol Neurodegener 16:29. https:\/\/doi.org\/10.1186\/s13024-021-00452-5","journal-title":"Mol Neurodegener"},{"key":"12314_CR131","doi-asserted-by":"publisher","DOI":"10.1242\/jcs.180745","author":"X Yan","year":"2016","unstructured":"Yan X, Nyk\u00e4nen N-P, Brunello CA, Haapasalo A, Hiltunen M, Uronen R-L, Huttunen HJ (2016) FRMD4A-cytohesin signaling modulates cellular release of tau. J Cell Sci. https:\/\/doi.org\/10.1242\/jcs.180745","journal-title":"J Cell Sci"},{"key":"12314_CR132","doi-asserted-by":"publisher","first-page":"847","DOI":"10.32604\/biocell.2022.018144","volume":"46","author":"MA Al Kabbani","year":"2022","unstructured":"Al Kabbani MA, Wunderlich G, K\u00f6hler C, Zempel H (2022) AAV-based gene therapy approaches for genetic forms of tauopathies and related neurogenetic disorders. Biocell 46:847\u2013853. https:\/\/doi.org\/10.32604\/biocell.2022.018144","journal-title":"Biocell"},{"key":"12314_CR133","doi-asserted-by":"publisher","first-page":"2179","DOI":"10.1007\/s12031-020-01776-5","volume":"71","author":"L Pan","year":"2021","unstructured":"Pan L, Meng L, He M, Zhang Z (2021) Tau in the pathophysiology of Parkinson\u2019s disease. J Mol Neurosci 71:2179\u20132191. https:\/\/doi.org\/10.1007\/s12031-020-01776-5","journal-title":"J Mol Neurosci"},{"key":"12314_CR134","doi-asserted-by":"publisher","unstructured":"Shahmoradian SH, Lewis AJ, Genoud C, Hench J, Moors TE, Navarro PP, Casta\u00f1o-D\u00edez D, Schweighauser G, Graff-Meyer A, Goldie KN, S\u00fctterlin R, Huisman E, Ingrassia A, de Gier Y, Rozemuller AJM, Wang J, De Paepe A, Erny J, Staempfli A, Hoernschemeyer J, Gro\u00dfer\u00fcschkamp F, Niedieker D, El-Mashtoly SF, Quadri M, Van IJcken WFJ, Bonifati V, Gerwert K, Bohrmann B, Frank S, Britschgi M, Stahlberg H, Van de Berg, WDJ, Lauer ME (2019) Lewy pathology in Parkinson\u2019s disease consists of crowded organelles and lipid membranes. Nature Neurosci22:1099\u20131109. https:\/\/doi.org\/10.1038\/s41593-019-0423-2","DOI":"10.1038\/s41593-019-0423-2"},{"key":"12314_CR135","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1007\/s004010050002","volume":"100","author":"K Arima","year":"2000","unstructured":"Arima K, Mizutani T, Alim MA, Tonozuka-Uehara H, Izumiyama Y, Hirai S, U\u00e9da K (2000) NACP\/\u03b1-synuclein and tau constitute two distinctive subsets of filaments in the same neuronal inclusions in brains from a family of parkinsonism and dementia with lewy bodies: double-immunolabeling fluorescence and electron microscopic studies. Acta Neuropathol 100:115\u2013121. https:\/\/doi.org\/10.1007\/s004010050002","journal-title":"Acta Neuropathol"},{"key":"12314_CR136","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1001\/archneur.60.3.387","volume":"60","author":"D Aarsland","year":"2003","unstructured":"Aarsland D, Andersen K, Larsen JP, Lolk A (2003) Prevalence and characteristics of dementia in Parkinson disease. Arch Neurol 60:387. https:\/\/doi.org\/10.1001\/archneur.60.3.387","journal-title":"Arch Neurol"},{"key":"12314_CR137","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fnagi.2021.743754","volume":"13","author":"J Han","year":"2021","unstructured":"Han J, Fan Y, Wu P, Huang Z, Li X, Zhao L, Ji Y, Zhu M (2021) Parkinson\u2019s disease dementia: synergistic effects of alpha-synuclein, tau, beta-amyloid, and iron. Front Aging Neurosci 13:1\u201313. https:\/\/doi.org\/10.3389\/fnagi.2021.743754","journal-title":"Front Aging Neurosci"},{"key":"12314_CR138","doi-asserted-by":"publisher","first-page":"626","DOI":"10.1038\/nrn3549.Parkinson","volume":"14","author":"DJ Irwin","year":"2013","unstructured":"Irwin DJ, Lee VM, Trojanowski JQ (2013) Amyloid beta-peptide and the dementia of Parkinson\u2019s disease. Nat Rev Neurosci 14:626\u2013636. https:\/\/doi.org\/10.1038\/nrn3549.Parkinson","journal-title":"Nat Rev Neurosci"},{"key":"12314_CR139","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s40478-019-0836-x","volume":"7","author":"MX Henderson","year":"2019","unstructured":"Henderson MX, Sengupta M, Trojanowski JQ, Lee VMY (2019) Alzheimer\u2019s disease tau is a prominent pathology in LRRK2 Parkinson\u2019s disease. Acta Neuropathol Commun 7:1\u201316. https:\/\/doi.org\/10.1186\/s40478-019-0836-x","journal-title":"Acta Neuropathol Commun"},{"key":"12314_CR140","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1002\/mds.26815","volume":"32","author":"M Sanchez-Contreras","year":"2017","unstructured":"Sanchez-Contreras M, Heckman MG, Tacik P, Diehl N, Brown PH, Soto-Ortolaza AI, Christopher EA, Walton RL, Ross OA, Golbe LI, Graff-Radford N, Wszolek ZK, Dickson DW, Rademakers R (2017) Study of LRRK2 variation in tauopathy: progressive supranuclear palsy and corticobasal degeneration. Mov Disord 32:115\u2013123. https:\/\/doi.org\/10.1002\/mds.26815","journal-title":"Mov Disord"},{"key":"12314_CR141","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1002\/ana.21157","volume":"62","author":"CP Zabetian","year":"2007","unstructured":"Zabetian CP, Hutter CM, Factor SA, Nutt JG, Higgins DS, Griffith A, Roberts JW, Leis BC, Kay DM, Yearout D, Montimurro JS, Edwards KL, Samii A, Payami H (2007) Association analysis of MAPT H1 haplotype and subhaplotypes in Parkinson\u2019s disease. Ann Neurol 62:137\u2013144. https:\/\/doi.org\/10.1002\/ana.21157","journal-title":"Ann Neurol"},{"key":"12314_CR142","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1186\/s40478-023-01534-9","volume":"11","author":"CV Tauber","year":"2023","unstructured":"Tauber CV, Schwarz SC, R\u00f6sler TW, Arzberger T, Gentleman S, Windl O, Krumbiegel M, Reis A, Ruf VC, Herms J, H\u00f6glinger GU (2023) Different MAPT haplotypes influence expression of total MAPT in postmortem brain tissue. Acta Neuropathol Commun 11:40. https:\/\/doi.org\/10.1186\/s40478-023-01534-9","journal-title":"Acta Neuropathol Commun"},{"key":"12314_CR143","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1002\/iub.1367","volume":"67","author":"M Ye","year":"2015","unstructured":"Ye M, Zhou D, Zhou Y, Sun C (2015) Parkinson\u2019s disease-associated PINK1G309D mutation increases abnormal phosphorylation of tau. IUBMB Life 67:286\u2013290. https:\/\/doi.org\/10.1002\/iub.1367","journal-title":"IUBMB Life"},{"key":"12314_CR144","doi-asserted-by":"publisher","first-page":"3008","DOI":"10.1093\/hmg\/ddu011","volume":"23","author":"B Roy","year":"2014","unstructured":"Roy B, Jackson GR (2014) Interactions between tau and \u03b1-synuclein augment neurotoxicity in a drosophila model of Parkinson\u2019s disease. Hum Mol Genet 23:3008\u20133023. https:\/\/doi.org\/10.1093\/hmg\/ddu011","journal-title":"Hum Mol Genet"},{"key":"12314_CR145","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2023.112180","volume":"42","author":"H Bogetofte","year":"2023","unstructured":"Bogetofte H, Ryan BJ, Jensen P, Schmidt SI, Vergoossen DLE, Barnkob MB, Kiani LN, Chughtai U, Heon-Roberts R, Caiazza MC, McGuinness W, M\u00e1rquez-G\u00f3mez R, Vowles J, Bunn FS, Brandes J, Kilfeather P, Connor JP, Fernandes HJR, Caffrey TM, Meyer M, Cowley SA, Larsen MR, Wade-Martins R (2023) Post-translational proteomics platform identifies neurite outgrowth impairments in Parkinson\u2019s disease GBA-N370S dopamine neurons. Cell Rep 42:112180. https:\/\/doi.org\/10.1016\/j.celrep.2023.112180","journal-title":"Cell Rep"},{"key":"12314_CR146","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1007\/s12031-013-0099-0","volume":"51","author":"Y Wang","year":"2013","unstructured":"Wang Y, Liu W, He X, Zhou F (2013) Parkinson\u2019s disease-associated Dj-1 mutations increase abnormal phosphorylation of tau protein through Akt\/Gsk-3\u03b2 pathways. J Mol Neurosci 51:911\u2013918. https:\/\/doi.org\/10.1007\/s12031-013-0099-0","journal-title":"J Mol Neurosci"},{"key":"12314_CR147","doi-asserted-by":"publisher","first-page":"5030","DOI":"10.3390\/ijms21145030","volume":"21","author":"E Vacchi","year":"2020","unstructured":"Vacchi E, Kaelin-Lang A, Melli G (2020) Tau and alpha synuclein synergistic effect in neurodegenerative diseases: when the periphery is the core. Int J Mol Sci 21:5030. https:\/\/doi.org\/10.3390\/ijms21145030","journal-title":"Int J Mol Sci"},{"key":"12314_CR148","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13024-019-0306-8","volume":"14","author":"TF Outeiro","year":"2019","unstructured":"Outeiro TF, Koss DJ, Erskine D, Walker L, Kurzawa-Akanbi M, Burn D, Donaghy P, Morris C, Taylor JP, Thomas A, Attems J, McKeith I (2019) Dementia with Lewy bodies: an update and outlook. Mol Neurodegener 14:1\u201318. https:\/\/doi.org\/10.1186\/s13024-019-0306-8","journal-title":"Mol Neurodegener"},{"key":"12314_CR149","doi-asserted-by":"publisher","DOI":"10.1038\/s41531-021-00273-9","author":"K Men\u0161\u00edkov\u00e1","year":"2022","unstructured":"Men\u0161\u00edkov\u00e1 K, Mat\u011bj R, Colosimo C, Rosales R, Tu\u010dkov\u00e1 L, Ehrmann J, Hrabo\u0161 D, Kola\u0159\u00edkov\u00e1 K, Vodi\u010dka R, Vrt\u011bl R, Proch\u00e1zka M, Nevrl\u00fd M, Kaiserov\u00e1 M, Kur\u010dov\u00e1 S, Otruba P, Ka\u0148ovsk\u00fd P (2022) Lewy body disease or diseases with lewy bodies? npj Parkinson\u2019s Dis. https:\/\/doi.org\/10.1038\/s41531-021-00273-9","journal-title":"npj Parkinson\u2019s Dis"},{"key":"12314_CR150","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1186\/s40035-022-00325-x","volume":"11","author":"YY Fathy","year":"2022","unstructured":"Fathy YY, Jonkman LE, Bol JJ, Timmermans E, Jonker AJ, Rozemuller AJM, van de Berg WDJ (2022) Axonal degeneration in the anterior insular cortex is associated with Alzheimer\u2019s co-pathology in Parkinson\u2019s disease and dementia with Lewy bodies. Transl Neurodegener 11:52. https:\/\/doi.org\/10.1186\/s40035-022-00325-x","journal-title":"Transl Neurodegener"},{"key":"12314_CR151","doi-asserted-by":"publisher","first-page":"287","DOI":"10.3233\/JAD-160322","volume":"54","author":"I van Steenoven","year":"2016","unstructured":"van Steenoven I, Aarsland D, Weintraub D, Londos E, Blanc F, van der Flier WM, Teunissen CE, Mollenhauer B, Fladby T, Kramberger MG, Bonanni L, Lemstra AW (2016) Cerebrospinal fluid Alzheimer\u2019s disease biomarkers across the spectrum of Lewy body diseases: results from a large multicenter Cohort. Zetterberg, H., Ed. J Alzheimer\u2019s Dis 54:287\u2013295. https:\/\/doi.org\/10.3233\/JAD-160322","journal-title":"J Alzheimer\u2019s Dis"},{"key":"12314_CR152","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1186\/s40478-019-0765-8","volume":"7","author":"BR Smith","year":"2019","unstructured":"Smith BR, Nelson KM, Kemper LJ, Leinonen-Wright K, Petersen A, Keene CD, Ashe KH (2019) A soluble tau fragment generated by caspase-2 is associated with dementia in Lewy body disease. Acta Neuropathol Commun 7:124. https:\/\/doi.org\/10.1186\/s40478-019-0765-8","journal-title":"Acta Neuropathol Commun"},{"key":"12314_CR153","doi-asserted-by":"publisher","DOI":"10.1016\/B978-0-444-64076-5.00028-4","author":"MI Tolea","year":"2018","unstructured":"Tolea MI, Galvin JE (2018) The genetics of dementia with Lewy bodies. Handbook Clin Neurol. https:\/\/doi.org\/10.1016\/B978-0-444-64076-5.00028-4","journal-title":"Handbook Clin Neurol"},{"key":"12314_CR154","doi-asserted-by":"publisher","first-page":"269","DOI":"10.3233\/JAD-210365","volume":"83","author":"SJ Van Der Lee","year":"2021","unstructured":"Van Der Lee SJ, Van Steenoven I, Van De Beek M, Tesi N, Jansen IE, Van Schoor NM, Reinders MJT, Huisman M, Scheltens P, Teunissen CE, Holstege H, Van Der Flier WM, Lemstra AW (2021) Genetics contributes to concomitant pathology and clinical presentation in dementia with Lewy bodies. J Alzheimer\u2019s Dis 83:269\u2013279. https:\/\/doi.org\/10.3233\/JAD-210365","journal-title":"J Alzheimer\u2019s Dis"},{"key":"12314_CR155","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-019-43458-2","volume":"9","author":"A Rongve","year":"2019","unstructured":"Rongve A, Witoelar A, Ruiz A, Athanasiu L, Abdelnour C, Clarimon J, Heilmann-Heimbach S, Hern\u00e1ndez I, Moreno-Grau S, de Rojas I, Morenas-Rodr\u00edguez E, Fladby T, Sando SB, Br\u00e5then G, Blanc F, Bousiges O, Lemstra AW, van Steenoven I, Londos E, Almdahl IS, P\u00e5lhaugen L, Eriksen JA, Djurovic S, Stordal E, Saltvedt I, Ulstein ID, Bettella F, Desikan RS, Idland AV, Toft M, Pihlstr\u00f8m L, Snaedal J, T\u00e1rraga L, Boada M, Lle\u00f3 A, Stef\u00e1nsson H, Stef\u00e1nsson K, Ram\u00edrez A, Aarsland D, Andreassen OA (2019) GBA and APOE \u03954 associate with sporadic dementia with Lewy bodies in European genome wide association study. Sci Rep 9:1\u20138. https:\/\/doi.org\/10.1038\/s41598-019-43458-2","journal-title":"Sci Rep"},{"key":"12314_CR156","doi-asserted-by":"publisher","DOI":"10.17879\/freeneuropathology-2020-2613","author":"J Bencze","year":"2020","unstructured":"Bencze J, Seo W, Hye A, Aarsland D, Hortob\u00e1gyi T (2020) Dementia with Lewy bodies\u2014a clinicopathological update. Free Neuropathol. https:\/\/doi.org\/10.17879\/freeneuropathology-2020-2613","journal-title":"Free Neuropathol"},{"key":"12314_CR157","doi-asserted-by":"publisher","first-page":"6139","DOI":"10.1093\/hmg\/ddu334","volume":"23","author":"J Bras","year":"2014","unstructured":"Bras J, Guerreiro R, Darwent L, Parkkinen L, Ansorge O, Escott-Price V, Hernandez DG, Nalls MA, Clark LN, Honig LS, Marder K, Van Der Flier WM, Lemstra A, Scheltens P, Rogaeva E, St George-Hyslop P, Londos E, Zetterberg H, Ortega-Cubero S, Pastor P, Ferman TJ, Graff-Radford NR, Ross OA, Barber I, Braae A, Brown K, Morgan K, Maetzler W, Berg D, Troakes C, Al-Sarraj S, Lashley T, Compta Y, Revesz T, Lees A, Cairns N, Halliday GM, Mann D, Pickering-Brown S, Dickson DW, Singleton A, Hardy J (2014) Genetic analysis implicates APOE, SNCA and suggests lysosomal dysfunction in the etiology of dementia with Lewy bodies. Hum Mol Genet 23:6139\u20136146. https:\/\/doi.org\/10.1093\/hmg\/ddu334","journal-title":"Hum Mol Genet"},{"key":"12314_CR158","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1038\/s41588-021-00785-3","volume":"53","author":"R Chia","year":"2021","unstructured":"Chia R, Sabir MS, Bandres-Ciga S, Saez-Atienzar S, Reynolds RH, Gustavsson E, Walton RL, Ahmed S, Viollet C, Ding J, Makarious MB, Diez-Fairen M, Portley MK, Shah Z, Abramzon Y, Hernandez DG, Blauwendraat C, Stone DJ, Eicher J, Parkkinen L, Ansorge O, Clark L, Honig LS, Marder K, Lemstra A, St George-Hyslop P, Londos E, Morgan K, Lashley T, Warner TT, Jaunmuktane Z, Galasko D, Santana I, Tienari PJ, Myllykangas L, Oinas M, Cairns NJ, Morris JC, Halliday GM, Van Deerlin VM, Trojanowski JQ, Grassano M, Calvo A, Mora G, Canosa A, Floris G, Bohannan RC, Brett F, Gan-Or Z, Geiger JT, Moore A, May P, Kr\u00fcger R, Goldstein DS, Lopez G, Tayebi N, Sidransky E, Sotis AR, Sukumar G, Alba C, Lott N, Martinez EMG, Tuck M, Singh J, Bacikova D, Zhang X, Hupalo DN, Adeleye A, Wilkerson MD, Pollard HB, Norcliffe-Kaufmann L, Palma JA, Kaufmann H, Shakkottai VG, Perkins M, Newell KL, Gasser T, Schulte C, Landi F, Salvi E, Cusi D, Masliah E, Kim RC, Caraway CA, Monuki ES, Brunetti M, Dawson TM, Rosenthal LS, Albert MS, Pletnikova O, Troncoso JC, Flanagan ME, Mao Q, Bigio EH, Rodr\u00edguez-Rodr\u00edguez E, Infante J, Lage C, Gonz\u00e1lez-Aramburu I et al (2021) Genome sequencing analysis identifies new loci associated with Lewy body dementia and provides insights into its genetic architecture. Nat Genet 53:294\u2013303. https:\/\/doi.org\/10.1038\/s41588-021-00785-3","journal-title":"Nat Genet"},{"key":"12314_CR159","doi-asserted-by":"publisher","first-page":"931","DOI":"10.1016\/j.celrep.2016.09.063","volume":"17","author":"S Calafate","year":"2016","unstructured":"Calafate S, Flavin W, Verstreken P, Moechars D (2016) Loss of Bin1 promotes the propagation of tau pathology. Cell Rep 17:931\u2013940. https:\/\/doi.org\/10.1016\/j.celrep.2016.09.063","journal-title":"Cell Rep"},{"key":"12314_CR160","doi-asserted-by":"publisher","first-page":"3520","DOI":"10.1016\/j.celrep.2020.02.026","volume":"30","author":"P De Rossi","year":"2020","unstructured":"De Rossi P, Nomura T, Andrew RJ, Masse NY, Sampathkumar V, Musial TF, Sudwarts A, Recupero AJ, Le Metayer T, Hansen MT, Shim H-N, Krause SV, Freedman DJ, Bindokas VP, Kasthuri N, Nicholson DA, Contractor A, Thinakaran G (2020) Neuronal BIN1 regulates presynaptic neurotransmitter release and memory consolidation. Cell Rep 30:3520-3535.e7. https:\/\/doi.org\/10.1016\/j.celrep.2020.02.026","journal-title":"Cell Rep"},{"key":"12314_CR161","doi-asserted-by":"publisher","first-page":"573","DOI":"10.2217\/epi-2023-0211","volume":"15","author":"J-N Zhang","year":"2023","unstructured":"Zhang J-N, Li Q, Yang F (2023) Role of epigenetic modifications in Parkinson\u2019s disease. Epigenomics 15:573\u2013576. https:\/\/doi.org\/10.2217\/epi-2023-0211","journal-title":"Epigenomics"},{"key":"12314_CR162","doi-asserted-by":"publisher","first-page":"45","DOI":"10.3233\/JPD-201981","volume":"11","author":"M Borsche","year":"2021","unstructured":"Borsche M, Pereira SL, Klein C, Gr\u00fcnewald A (2021) Mitochondria and Parkinson\u2019s disease: clinical, molecular, and translational aspects. J Parkinson\u2019s Dis 11:45\u201360. https:\/\/doi.org\/10.3233\/JPD-201981","journal-title":"J Parkinson\u2019s Dis"},{"key":"12314_CR163","doi-asserted-by":"publisher","first-page":"11022","DOI":"10.3390\/ijms241311022","volume":"24","author":"AT Rodger","year":"2023","unstructured":"Rodger AT, ALNasser M, Carter WG (2023) Are therapies that target \u03b1-synuclein effective at halting Parkinson\u2019s disease progression? A systematic review. Int J Mol Sci 24:11022. https:\/\/doi.org\/10.3390\/ijms241311022","journal-title":"Int J Mol Sci"},{"key":"12314_CR164","doi-asserted-by":"publisher","first-page":"341","DOI":"10.3233\/JND-200598","volume":"8","author":"L Over","year":"2021","unstructured":"Over L, Br\u00fcggemann N, Lohmann K (2021) Therapies for genetic forms of Parkinson\u2019s disease: systematic literature review. Bonne, G., Ed. J Neuromuscul Dis 8:341\u2013356. https:\/\/doi.org\/10.3233\/JND-200598","journal-title":"J Neuromuscul Dis"},{"key":"12314_CR165","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1080\/02643294.2017.1340264","volume":"35","author":"D Bergeron","year":"2018","unstructured":"Bergeron D, Poulin S, Laforce R (2018) Cognition and anatomy of adult Niemann-Pick disease type C: insights for the Alzheimer field. Cogn Neuropsychol 35:209\u2013222. https:\/\/doi.org\/10.1080\/02643294.2017.1340264","journal-title":"Cogn Neuropsychol"},{"key":"12314_CR166","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.33534","author":"PJ V\u00e9lez Pinos","year":"2023","unstructured":"V\u00e9lez Pinos PJ, Saavedra Palacios MS, Colina Arteaga PA, Arevalo Cordova TD (2023) Niemann-Pick disease: a case report and literature review. Cureus. https:\/\/doi.org\/10.7759\/cureus.33534","journal-title":"Cureus"},{"key":"12314_CR167","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.nbd.2014.05.033","volume":"72","author":"M Malnar","year":"2014","unstructured":"Malnar M, Hecimovic S, Mattsson N, Zetterberg H (2014) Bidirectional links between Alzheimer\u2019s disease and Niemann-Pick type C disease. Neurobiol Dis 72:37\u201347. https:\/\/doi.org\/10.1016\/j.nbd.2014.05.033","journal-title":"Neurobiol Dis"},{"key":"12314_CR168","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1007\/BF00309338","volume":"89","author":"K Suzuki","year":"1995","unstructured":"Suzuki K, Parker CC, Pentchev PG, Katz D, Ghetti B, D\u2019Agostino AN, Carstea ED (1995) Neurofibrillary tangles in Niemann-Pick disease type C. Acta Neuropathol 89:227\u2013238. https:\/\/doi.org\/10.1007\/BF00309338","journal-title":"Acta Neuropathol"},{"key":"12314_CR169","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.neurobiolaging.2022.04.008","volume":"116","author":"X Xiao","year":"2022","unstructured":"Xiao X, Liao X, Zhou Y, Weng L, Guo L, Zhou L, Wang X, Liu X, Liu H, Bi X, Xu T, Zhu Y, Yang Q, Zhang S, Hao X, Liu Y, Zhang W, Li J, Shen L, Jiao B (2022) Variants in the Niemann-Pick type C genes are not associated with Alzheimer\u2019s disease: a large case-control study in the chinese population. Neurobiol Aging 116:49\u201354. https:\/\/doi.org\/10.1016\/j.neurobiolaging.2022.04.008","journal-title":"Neurobiol Aging"},{"key":"12314_CR170","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1016\/j.jocn.2019.06.025","volume":"68","author":"S Boenzi","year":"2019","unstructured":"Boenzi S, Dardis A, Russo P, Bellofatto M, Imbriglio T, Fico T, De Michele G, De Rosa A (2019) Screening for Niemann-Pick type C disease in neurodegenerative diseases. J Clin Neurosci 68:266\u2013267. https:\/\/doi.org\/10.1016\/j.jocn.2019.06.025","journal-title":"J Clin Neurosci"},{"key":"12314_CR171","doi-asserted-by":"publisher","first-page":"e82879","DOI":"10.1371\/journal.pone.0082879","volume":"8","author":"M Zech","year":"2013","unstructured":"Zech M, N\u00fcbling G, Castrop F, Jochim A, Schulte EC, Mollenhauer B, Lichtner P, Peters A, Gieger C, Marquardt T, Vanier MT, Latour P, Kl\u00fcnemann H, Trenkwalder C, Diehl-Schmid J, Perneczky R, Meitinger T, Oexle K, Haslinger B, Lorenzl S, Winkelmann J (2013) Niemann-Pick C disease gene mutations and age-related neurodegenerative disorders. Wider, C., Ed.,. PLoS ONE 8:e82879. https:\/\/doi.org\/10.1371\/journal.pone.0082879","journal-title":"PLoS ONE"},{"key":"12314_CR172","doi-asserted-by":"publisher","first-page":"548","DOI":"10.4161\/auto.5.4.8364","volume":"5","author":"CD Pacheco","year":"2009","unstructured":"Pacheco CD, Elrick MJ, Lieberman AP (2009) Tau normal function influences Niemann-Pick type C disease pathogenesis in mice and modulates autophagy in NPC1-deficient cells. Autophagy 5:548\u2013550. https:\/\/doi.org\/10.4161\/auto.5.4.8364","journal-title":"Autophagy"},{"key":"12314_CR173","doi-asserted-by":"publisher","first-page":"846","DOI":"10.1097\/NEN.0000000000000103","volume":"73","author":"F Gl\u00f6ckner","year":"2014","unstructured":"Gl\u00f6ckner F, Ohm TG (2014) Tau pathology induces intraneuronal cholesterol accumulation. J Neuropathol Exp Neurol 73:846\u2013854. https:\/\/doi.org\/10.1097\/NEN.0000000000000103","journal-title":"J Neuropathol Exp Neurol"},{"key":"12314_CR174","doi-asserted-by":"publisher","DOI":"10.15252\/embr.202357499","author":"L Szabo","year":"2023","unstructured":"Szabo L, Cummins N, Paganetti P, Odermatt A, Papassotiropoulos A, Karch C, G\u00f6tz J, Eckert A, Grimm A (2023) ER-mitochondria contacts and cholesterol metabolism are disrupted by disease-associated tau protein. EMBO Rep. https:\/\/doi.org\/10.15252\/embr.202357499","journal-title":"EMBO Rep"},{"key":"12314_CR175","doi-asserted-by":"publisher","first-page":"956","DOI":"10.1093\/hmg\/ddn423","volume":"18","author":"CD Pacheco","year":"2009","unstructured":"Pacheco CD, Elrick MJ, Lieberman AP (2009) Tau deletion exacerbates the phenotype of Niemann-Pick type C mice and implicates autophagy in pathogenesis. Hum Mol Genet 18:956\u2013965. https:\/\/doi.org\/10.1093\/hmg\/ddn423","journal-title":"Hum Mol Genet"},{"key":"12314_CR176","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1007\/s13353-020-00572-6","volume":"61","author":"AF Smith","year":"2020","unstructured":"Smith AF, Vanderah TW, Erickson RP (2020) Haploinsufficiency of tau decreases survival of the mouse model of Niemann-Pick disease type C1 but does not alter tau phosphorylation. J Appl Genet 61:567\u2013570. https:\/\/doi.org\/10.1007\/s13353-020-00572-6","journal-title":"J Appl Genet"},{"key":"12314_CR177","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1016\/S1474-4422(14)70090-0","volume":"13","author":"B Dubois","year":"2014","unstructured":"Dubois B, Feldman HH, Jacova C, Hampel H, Molinuevo JL, Blennow K, DeKosky ST, Gauthier S, Selkoe D, Bateman R, Cappa S, Crutch S, Engelborghs S, Frisoni GB, Fox NC, Galasko D, Habert M-O, Jicha GA, Nordberg A, Pasquier F, Rabinovici G, Robert P, Rowe C, Salloway S, Sarazin M, Epelbaum S, de Souza LC, Vellas B, Visser PJ, Schneider L, Stern Y, Scheltens P, Cummings JL (2014) Advancing research diagnostic criteria for Alzheimer\u2019s disease: the IWG-2 criteria. Lancet Neurol 13:614\u2013629. https:\/\/doi.org\/10.1016\/S1474-4422(14)70090-0","journal-title":"Lancet Neurol"},{"key":"12314_CR178","doi-asserted-by":"publisher","first-page":"930","DOI":"10.1016\/S1474-4422(21)00245-3","volume":"20","author":"J Fortea","year":"2022","unstructured":"Fortea J, Zaman SH, Hartley S, Rafii MS, Head E, Carmona-iragui M (2022) Down syndrome-associated Alzheimer\u2019s disease: a genetic form of dementia. Lancet Neurol 20:930\u2013942. https:\/\/doi.org\/10.1016\/S1474-4422(21)00245-3","journal-title":"Lancet Neurol"},{"key":"12314_CR179","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1002\/dad2.12288","volume":"14","author":"C Padilla","year":"2022","unstructured":"Padilla C, Montal V, Walpert MJ, Hong YT, Fryer TD, Coles JP, Aigbirhio FI, Hartley SL, Cohen AD, Tudorascu DL, Christian BT, Handen BL, Klunk WE, Holland AJ, Zaman SH (2022) Cortical atrophy and amyloid and tau deposition in down syndrome: a longitudinal study. Alzheimer\u2019s Dementia Diagn Assess Dis Monit 14:5. https:\/\/doi.org\/10.1002\/dad2.12288","journal-title":"Alzheimer\u2019s Dementia Diagn Assess Dis Monit"},{"key":"12314_CR180","doi-asserted-by":"publisher","first-page":"700","DOI":"10.1016\/j.jalz.2014.10.007","volume":"11","author":"D Hartley","year":"2015","unstructured":"Hartley D, Blumenthal T, Carrillo M, DiPaolo G, Esralew L, Gardiner K, Granholm AC, Iqbal K, Krams M, Lemere C, Lott I, Mobley W, Ness S, Nixon R, Potter H, Reeves R, Sabbagh M, Silverman W, Tycko B, Whitten M, Wisniewski T (2015) Down syndrome and Alzheimer\u2019s disease: common pathways, common goals. Alzheimer\u2019s Dementia 11:700\u2013709. https:\/\/doi.org\/10.1016\/j.jalz.2014.10.007","journal-title":"Alzheimer\u2019s Dementia"},{"key":"12314_CR181","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1002\/dad2.12256","volume":"14","author":"SL Hartley","year":"2022","unstructured":"Hartley SL, Handen BL, Tudorascu D, Lee L, Cohen A, Piro-Gambetti B, Zammit M, Klunk W, Laymon C, Zaman S, Ances BM, Sabbagh M, Christian BT (2022) Role of tau deposition in early cognitive decline in down syndrome. Alzheimer\u2019s Dementia Diagn Assess Dis Monit 14:5. https:\/\/doi.org\/10.1002\/dad2.12256","journal-title":"Alzheimer\u2019s Dementia Diagn Assess Dis Monit"},{"key":"12314_CR182","doi-asserted-by":"publisher","first-page":"1171","DOI":"10.1007\/s00401-022-02500-w","volume":"144","author":"S Ichimata","year":"2022","unstructured":"Ichimata S, Martinez-Valbuena I, Forrest SL, Kovacs GG (2022) Expanding the spectrum of amyloid-\u03b2 plaque pathology: the down syndrome associated \u2018bird-nest plaque.\u2019 Acta Neuropathol 144:1171\u20131174. https:\/\/doi.org\/10.1007\/s00401-022-02500-w","journal-title":"Acta Neuropathol"},{"key":"12314_CR183","doi-asserted-by":"publisher","first-page":"595","DOI":"10.3233\/JAD-215675","volume":"87","author":"S Ichimata","year":"2022","unstructured":"Ichimata S, Yoshida K, Visanji NP, Lang AE, Nishida N, Kovacs GG (2022) Patterns of mixed pathologies in down syndrome. Giaccone, G., Ed.,. J Alzheimer\u2019s Dis 87:595\u2013607. https:\/\/doi.org\/10.3233\/JAD-215675","journal-title":"J Alzheimer\u2019s Dis"},{"key":"12314_CR184","doi-asserted-by":"publisher","first-page":"459","DOI":"10.3233\/JAD-160836","volume":"56","author":"E Doran","year":"2017","unstructured":"Doran E, Keator D, Head E, Phelan MJ, Kim R, Totoiu M, Barrio JR, Small GW, Potkin SG, Lott IT (2017) Down syndrome, partial trisomy 21, and absence of Alzheimer\u2019s disease: the role of APP. Fortea, J., Ed.,. J Alzheimer\u2019s Dis 56:459\u2013470. https:\/\/doi.org\/10.3233\/JAD-160836","journal-title":"J Alzheimer\u2019s Dis"},{"key":"12314_CR185","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1242\/dmm.008078","volume":"4","author":"E Lana-Elola","year":"2011","unstructured":"Lana-Elola E, Watson-Scales SD, Fisher EMC, Tybulewicz VLJ (2011) Down syndrome: searching for the genetic culprits. Dis Model Mech 4:586\u2013595. https:\/\/doi.org\/10.1242\/dmm.008078","journal-title":"Dis Model Mech"},{"key":"12314_CR186","doi-asserted-by":"publisher","first-page":"5736","DOI":"10.1038\/s41598-021-85062-3","volume":"11","author":"JL Tosh","year":"2021","unstructured":"Tosh JL, Rhymes ER, Mumford P, Whittaker HT, Pulford LJ, Noy SJ, Cleverley K, Strydom A, Fisher E, Wiseman F, Nizetic D, Hardy J, Tybulewicz V, Karmiloff-Smith A, Walker MC, Tybulewicz VLJ, Wykes RC, Fisher EMC, Wiseman FK (2021) Genetic dissection of down syndrome-associated alterations in APP\/amyloid-\u03b2 biology using mouse models. Sci Rep 11:5736. https:\/\/doi.org\/10.1038\/s41598-021-85062-3","journal-title":"Sci Rep"},{"key":"12314_CR187","doi-asserted-by":"publisher","first-page":"34850","DOI":"10.1074\/jbc.M707358200","volume":"282","author":"S-R Ryoo","year":"2007","unstructured":"Ryoo S-R, Jeong HK, Radnaabazar C, Yoo J-J, Cho H-J, Lee H-W, Kim I-S, Cheon Y-H, Ahn YS, Chung S-H, Song W-J (2007) DYRK1A-mediated hyperphosphorylation of tau. J Biol Chem 282:34850\u201334857. https:\/\/doi.org\/10.1074\/jbc.M707358200","journal-title":"J Biol Chem"},{"key":"12314_CR188","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.neurobiolaging.2022.07.003","volume":"119","author":"M Grigorova","year":"2022","unstructured":"Grigorova M, Mak E, Brown SSG, Beresford-Webb J, Hong YT, Fryer TD, Coles JP, Aigbirhio FI, Tudorascu D, Cohen A, Christian BT, Ances B, Handen BL, Laymon CM, Klunk WE, Clare ICH, Holland AJ, Zaman SH (2022) Amyloid- \u03b2 and tau deposition influences cognitive and functional decline in down syndrome. Neurobiol Aging 119:36\u201345. https:\/\/doi.org\/10.1016\/j.neurobiolaging.2022.07.003","journal-title":"Neurobiol Aging"},{"key":"12314_CR189","doi-asserted-by":"publisher","first-page":"102740","DOI":"10.1016\/j.nicl.2021.102740","volume":"31","author":"MD Zammit","year":"2021","unstructured":"Zammit MD, Tudorascu DL, Laymon CM, Hartley SL, Ellison PA, Zaman SH, Ances BM, Johnson SC, Stone CK, Sabbagh MN, Mathis CA, Klunk WE, Cohen AD, Handen BL, Christian BT (2021) Neurofibrillary tau depositions emerge with subthreshold cerebral beta-amyloidosis in down syndrome. NeuroImage Clin 31:102740. https:\/\/doi.org\/10.1016\/j.nicl.2021.102740","journal-title":"NeuroImage Clin"},{"key":"12314_CR190","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1093\/hmg\/ddl437","volume":"16","author":"R Kimura","year":"2007","unstructured":"Kimura R, Kamino K, Yamamoto M, Nuripa A, Kida T, Kazui H, Hashimoto R, Tanaka T, Kudo T, Yamagata H, Tabara Y, Miki T, Akatsu H, Kosaka K, Funakoshi E, Nishitomi K, Sakaguchi G, Kato A, Hattori H, Uema T, Takeda M (2007) The DYRK1A gene, encoded in chromosome 21 down syndrome critical region, bridges between \u03b2-amyloid production and tau phosphorylation in Alzheimer disease. Hum Mol Genet 16:15\u201323. https:\/\/doi.org\/10.1093\/hmg\/ddl437","journal-title":"Hum Mol Genet"},{"key":"12314_CR191","doi-asserted-by":"publisher","first-page":"3224","DOI":"10.1096\/fj.07-104539","volume":"22","author":"F Liu","year":"2008","unstructured":"Liu F, Liang Z, Wegiel J, Hwang Y, Iqbal K, Grundke-Iqbal I, Ramakrishna N, Gong C (2008) Overexpression of Dyrk1A contributes to neurofibrillary degeneration in down syndrome. FASEB J 22:3224\u20133233. https:\/\/doi.org\/10.1096\/fj.07-104539","journal-title":"FASEB J"},{"key":"12314_CR192","doi-asserted-by":"publisher","first-page":"28660","DOI":"10.1074\/jbc.M802645200","volume":"283","author":"J Shi","year":"2008","unstructured":"Shi J, Zhang T, Zhou C, Chohan MO, Gu X, Wegiel J, Zhou J, Hwang Y-W, Iqbal K, Grundke-Iqbal I, Gong C-X, Liu F (2008) Increased dosage of Dyrk1A alters alternative splicing factor (ASF)-regulated alternative splicing of tau in down syndrome. J Biol Chem 283:28660\u201328669. https:\/\/doi.org\/10.1074\/jbc.M802645200","journal-title":"J Biol Chem"},{"key":"12314_CR193","doi-asserted-by":"publisher","DOI":"10.3389\/fnbeh.2016.00104","author":"A Duchon","year":"2016","unstructured":"Duchon A, Herault Y (2016) DYRK1A, a dosage-sensitive gene involved in neurodevelopmental disorders, is a target for drug development in down syndrome. Front Behav Neurosci. https:\/\/doi.org\/10.3389\/fnbeh.2016.00104","journal-title":"Front Behav Neurosci"},{"key":"12314_CR194","doi-asserted-by":"publisher","DOI":"10.1242\/dmm.025668","author":"H Kim","year":"2016","unstructured":"Kim H, Lee K-S, Kim A-K, Choi M, Choi K, Kang M, Chi S-W, Lee M-S, Lee J-S, Lee S-Y, Song W-J, Yu K, Cho S (2016) A chemical with proven clinical safety restores down syndrome-related phenotypes via DYRK1A inhibition. Dis Model Mech. https:\/\/doi.org\/10.1242\/dmm.025668","journal-title":"Dis Model Mech"},{"key":"12314_CR195","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1186\/s40478-019-0678-6","volume":"7","author":"B Souchet","year":"2019","unstructured":"Souchet B, Audrain M, Billard JM, Dairou J, Fol R, Orefice NS, Tada S, Gu Y, Dufayet-Chaffaud G, Limanton E, Carreaux F, Bazureau J-P, Alves S, Meijer L, Janel N, Braudeau J, Cartier N (2019) Inhibition of DYRK1A proteolysis modifies its kinase specificity and rescues Alzheimer phenotype in APP\/PS1 mice. Acta Neuropathol Commun 7:46. https:\/\/doi.org\/10.1186\/s40478-019-0678-6","journal-title":"Acta Neuropathol Commun"},{"key":"12314_CR196","doi-asserted-by":"publisher","first-page":"4","DOI":"10.3389\/fphar.2022.881385","volume":"13","author":"B Zhu","year":"2022","unstructured":"Zhu B, Parsons T, Stensen W, Mj\u00f8en Svendsen JS, Fugelli A, Hodge JJL (2022) DYRK1a inhibitor mediated rescue of drosophila models of Alzheimer\u2019s disease-down syndrome phenotypes. Front Pharmacol 13:4. https:\/\/doi.org\/10.3389\/fphar.2022.881385","journal-title":"Front Pharmacol"},{"key":"12314_CR197","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1002\/ana.26321","volume":"91","author":"ME Curtis","year":"2022","unstructured":"Curtis ME, Smith T, Yu D, Pratic\u00f2 D (2022) Association of retromer deficiency and tau pathology in down syndrome. Ann Neurol 91:561\u2013567. https:\/\/doi.org\/10.1002\/ana.26321","journal-title":"Ann Neurol"},{"key":"12314_CR198","doi-asserted-by":"publisher","DOI":"10.1007\/978-981-32-9358-8_17","author":"F Fernandez-Gomez","year":"2019","unstructured":"Fernandez-Gomez F, Tran H, Dhaenens C-M, Caillet-Boudin M-L, Schraen-Maschke S, Blum D, Sablonni\u00e8re B, Bu\u00e9e-Scherrer V, Buee L, Sergeant N (2019) Myotonic dystrophy: an RNA toxic gain of function tauopathy? Tau Biol. https:\/\/doi.org\/10.1007\/978-981-32-9358-8_17","journal-title":"Tau Biol"},{"key":"12314_CR199","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1016\/0092-8674(92)90154-5","volume":"68","author":"JD Brook","year":"1992","unstructured":"Brook JD, McCurrach ME, Harley HG, Buckler AJ, Church D, Aburatani H, Hunter K, Stanton VP, Thirion JP, Hudson T (1992) Molecular basis of myotonic dystrophy: expansion of a trinucleotide (CTG) repeat at the 3\u2019 end of a transcript encoding a protein kinase family member. Cell 68:799\u2013808. https:\/\/doi.org\/10.1016\/0092-8674(92)90154-5","journal-title":"Cell"},{"key":"12314_CR200","doi-asserted-by":"publisher","first-page":"4","DOI":"10.3389\/fnagi.2021.755392","volume":"13","author":"J Liu","year":"2021","unstructured":"Liu J, Guo Z-N, Yan X-L, Yang Y, Huang S (2021) Brain pathogenesis and potential therapeutic strategies in myotonic dystrophy type 1. Front Aging Neurosci 13:4. https:\/\/doi.org\/10.3389\/fnagi.2021.755392","journal-title":"Front Aging Neurosci"},{"key":"12314_CR201","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1016\/j.expneurol.2007.11.020","volume":"210","author":"CM Dhaenens","year":"2008","unstructured":"Dhaenens CM, Schraen-Maschke S, Tran H, Vingtdeux V, Ghanem D, Leroy O, Delplanque J, Vanbrussel E, Delacourte A, Vermersch P, Maurage CA, Gruffat H, Sergeant A, Mahadevan MS, Ishiura S, Bu\u00e9e L, Cooper TA, Caillet-Boudin ML, Charlet-Berguerand N, Sablonni\u00e8re B, Sergeant N (2008) Overexpression of MBNL1 fetal isoforms and modified splicing of tau in the DM1 brain: two individual consequences of CUG trinucleotide repeats. Exp Neurol 210:467\u2013478. https:\/\/doi.org\/10.1016\/j.expneurol.2007.11.020","journal-title":"Exp Neurol"},{"key":"12314_CR202","doi-asserted-by":"publisher","first-page":"732","DOI":"10.1016\/j.bbadis.2011.03.010","volume":"1812","author":"CM Dhaenens","year":"2011","unstructured":"Dhaenens CM, Tran H, Frandemiche M-L, Carpentier C, Schraen-Maschke S, Sistiaga A, Goicoechea M, Eddarkaoui S, Van Brussels E, Obriot H, Labudeck A, Gevaert MH, Fernandez-Gomez F, Charlet-Berguerand N, Deramecourt V, Maurage CA, Bu\u00e9e L, de Munain AL, Sablonni\u00e8re B, Caillet-Boudin ML, Sergeant N (2011) Mis-splicing of tau exon 10 in myotonic dystrophy type 1 is reproduced by overexpression of CELF2 but not by MBNL1 silencing. Biochimica et Biophysica Acta BBA Mol Basis Dis 1812:732\u2013742. https:\/\/doi.org\/10.1016\/j.bbadis.2011.03.010","journal-title":"Biochimica et Biophysica Acta BBA Mol Basis Dis"},{"key":"12314_CR203","doi-asserted-by":"publisher","unstructured":"Weijs R, Okkersen K, van Engelen B, K\u00fcsters B, Lammens M, Aronica E, Raaphorst J, van Cappellen van Walsum A (2021) Human brain pathology in myotonic dystrophy type 1: a systematic review. Neuropathology41:3\u201320. https:\/\/doi.org\/10.1111\/neup.12721","DOI":"10.1111\/neup.12721"},{"key":"12314_CR204","doi-asserted-by":"publisher","first-page":"3079","DOI":"10.1093\/hmg\/ddh327","volume":"13","author":"H Jiang","year":"2004","unstructured":"Jiang H, Mankodi A, Swanson MS, Moxley RT, Thornton CA (2004) Myotonic dystrophy type 1 is associated with nuclear foci of mutant RNA, sequestration of muscleblind proteins and deregulated alternative splicing in neurons. Hum Mol Genet 13:3079\u20133088. https:\/\/doi.org\/10.1093\/hmg\/ddh327","journal-title":"Hum Mol Genet"},{"key":"12314_CR205","doi-asserted-by":"publisher","first-page":"5","DOI":"10.3389\/fnmol.2013.00057","volume":"6","author":"M-L Caillet-Boudin","year":"2014","unstructured":"Caillet-Boudin M-L, Fernandez-Gomez F-J, Tran H, Dhaenens C-M, Buee L, Sergeant N (2014) Brain pathology in myotonic dystrophy: when tauopathy meets spliceopathy and RNAopathy. Front Mol Neurosci 6:5. https:\/\/doi.org\/10.3389\/fnmol.2013.00057","journal-title":"Front Mol Neurosci"},{"key":"12314_CR206","doi-asserted-by":"publisher","first-page":"3579","DOI":"10.1007\/s00415-022-10970-x","volume":"269","author":"RJ Laforce","year":"2022","unstructured":"Laforce RJ, Dallaire-Th\u00e9roux C, Racine AM, Dent G, Salinas-Valenzuela C, Poulin E, Cayer A-M, B\u00e9dard-Tremblay D, Rouleau-Bonenfant T, St-Onge F, Schraen-Maschke S, Beauregard J-M, Sergeant N, Puymirat J (2022) Tau positron emission tomography, cerebrospinal fluid and plasma biomarkers of neurodegeneration, and neurocognitive testing: an exploratory study of participants with myotonic dystrophy type 1. J Neurol 269:3579\u20133587. https:\/\/doi.org\/10.1007\/s00415-022-10970-x","journal-title":"J Neurol"},{"key":"12314_CR207","doi-asserted-by":"publisher","first-page":"1109","DOI":"10.3390\/genes11091109","volume":"11","author":"A L\u00f3pez-Mart\u00ednez","year":"2020","unstructured":"L\u00f3pez-Mart\u00ednez A, Soblechero-Mart\u00edn P, De-la-Puente-Ovejero L, Nogales-Gadea G, Arechavala-Gomeza V (2020) An overview of alternative splicing defects implicated in myotonic dystrophy type I. Genes 11:1109. https:\/\/doi.org\/10.3390\/genes11091109","journal-title":"Genes"},{"key":"12314_CR208","doi-asserted-by":"publisher","first-page":"1221","DOI":"10.3233\/JAD-132450","volume":"42","author":"CJ Holler","year":"2014","unstructured":"Holler CJ, Davis PR, Beckett TL, Platt TL, Webb RL, Head E, Murphy MP (2014) Bridging integrator 1 (BIN1) protein expression increases in the Alzheimer\u2019s disease brain and correlates with neurofibrillary tangle pathology. J Alzheimer\u2019s Dis 42:1221\u20131227. https:\/\/doi.org\/10.3233\/JAD-132450","journal-title":"J Alzheimer\u2019s Dis"},{"key":"12314_CR209","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1267\/ahc.10019","volume":"43","author":"K Itoh","year":"2010","unstructured":"Itoh K, Mitani M, Kawamoto K, Futamura N, Funakawa I, Jinnai K, Fushiki S (2010) Neuropathology does not correlate with regional differences in the extent of expansion of CTG repeats in the brain with myotonic dystrophy type 1. Acta Histochem Cytochem 43:149\u2013156. https:\/\/doi.org\/10.1267\/ahc.10019","journal-title":"Acta Histochem Cytochem"},{"key":"12314_CR210","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1111\/neup.12790","volume":"42","author":"T Sano","year":"2022","unstructured":"Sano T, Kawazoe T, Shioya A, Mori-Yoshimura M, Oya Y, Maruo K, Nishino I, Hoshino M, Murayama S, Saito Y (2022) Unique Lewy pathology in myotonic dystrophy type 1. Neuropathology 42:104\u2013116. https:\/\/doi.org\/10.1111\/neup.12790","journal-title":"Neuropathology"},{"key":"12314_CR211","doi-asserted-by":"publisher","first-page":"S59","DOI":"10.3233\/JND-150088","volume":"2","author":"G Meola","year":"2015","unstructured":"Meola G, Cardani R (2015) Myotonic dystrophy type 2: an update on clinical aspects, genetic and pathomolecular mechanism. J Neuromuscul Dis 2:S59\u2013S71. https:\/\/doi.org\/10.3233\/JND-150088","journal-title":"J Neuromuscul Dis"},{"key":"12314_CR212","doi-asserted-by":"publisher","first-page":"864","DOI":"10.1126\/science.1062125","volume":"293","author":"CL Liquori","year":"2001","unstructured":"Liquori CL, Ricker K, Moseley ML, Jacobsen JF, Kress W, Naylor SL, Day JW, Ranum LP (2001) Myotonic dystrophy type 2 caused by a CCTG expansion in intron 1 of ZNF9. Science 293:864\u2013867. https:\/\/doi.org\/10.1126\/science.1062125","journal-title":"Science"},{"key":"12314_CR213","doi-asserted-by":"publisher","first-page":"1636","DOI":"10.1212\/01.wnl.0000184585.93864.4e","volume":"65","author":"CA Maurage","year":"2005","unstructured":"Maurage CA, Udd B, Ruchoux MM, Vermersch P, Kalimo H, Krahe R, Delacourte A, Sergeant N (2005) Similar brain tau pathology in DM2\/PROMM and DM1\/Steinert disease. Neurology 65:1636\u20131638. https:\/\/doi.org\/10.1212\/01.wnl.0000184585.93864.4e","journal-title":"Neurology"},{"key":"12314_CR214","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1016\/0092-8674(93)90585-E","volume":"72","author":"The Huntington\u2019s Disease Collaborative Research Group","year":"1993","unstructured":"The Huntington\u2019s Disease Collaborative Research Group (1993) A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington\u2019s disease chromosomes. Cell 72:971\u2013983. https:\/\/doi.org\/10.1016\/0092-8674(93)90585-E","journal-title":"Cell"},{"key":"12314_CR215","doi-asserted-by":"publisher","first-page":"e382","DOI":"10.1038\/cddis.2012.121","volume":"3","author":"G Cisbani","year":"2012","unstructured":"Cisbani G, Cicchetti F (2012) An in vitro perspective on the molecular mechanisms underlying mutant huntingtin protein toxicity. Cell Death Dis 3:e382\u2013e382. https:\/\/doi.org\/10.1038\/cddis.2012.121","journal-title":"Cell Death Dis"},{"key":"12314_CR216","doi-asserted-by":"publisher","first-page":"1014","DOI":"10.1093\/brain\/aww021","volume":"139","author":"M Gratuze","year":"2016","unstructured":"Gratuze M, Cisbani G, Cicchetti F, Planel E (2016) Is Huntington\u2019s disease a tauopathy? Brain 139:1014\u20131025. https:\/\/doi.org\/10.1093\/brain\/aww021","journal-title":"Brain"},{"key":"12314_CR217","doi-asserted-by":"publisher","first-page":"15","DOI":"10.3233\/JHD-220557","volume":"12","author":"S Salem","year":"2023","unstructured":"Salem S, Cicchetti F (2023) Untangling the role of tau in Huntington\u2019s disease pathology. J Huntington\u2019s Dis 12:15\u201329. https:\/\/doi.org\/10.3233\/JHD-220557","journal-title":"J Huntington\u2019s Dis"},{"key":"12314_CR218","doi-asserted-by":"publisher","first-page":"1907","DOI":"10.1093\/brain\/awv107","volume":"138","author":"R Vuono","year":"2015","unstructured":"Vuono R, Winder-Rhodes S, de Silva R, Cisbani G, Drouin-Ouellet J, Spillantini MG, Cicchetti F, Barker RA (2015) The role of tau in the pathological process and clinical expression of Huntington\u2019s disease. Brain 138:1907\u20131918. https:\/\/doi.org\/10.1093\/brain\/awv107","journal-title":"Brain"},{"key":"12314_CR219","doi-asserted-by":"publisher","first-page":"5","DOI":"10.3389\/fneur.2020.580732","volume":"11","author":"M Masnata","year":"2020","unstructured":"Masnata M, Salem S, de Rus Jacquet A, Anwer M, Cicchetti F (2020) Targeting tau to treat clinical features of Huntington\u2019s disease. Front Neurol 11:5. https:\/\/doi.org\/10.3389\/fneur.2020.580732","journal-title":"Front Neurol"},{"key":"12314_CR220","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1016\/j.neuroscience.2022.07.014","volume":"518","author":"S Petry","year":"2023","unstructured":"Petry S, Nateghi B, Keraudren R, Sergeant N, Planel E, H\u00e9bert SS, St-Amour I (2023) Differential regulation of tau Exon 2 and 10 isoforms in Huntington\u2019s disease brain. Neuroscience 518:54\u201363. https:\/\/doi.org\/10.1016\/j.neuroscience.2022.07.014","journal-title":"Neuroscience"},{"key":"12314_CR221","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1038\/nm.3617","volume":"20","author":"M Fern\u00e1ndez-Nogales","year":"2014","unstructured":"Fern\u00e1ndez-Nogales M, Cabrera JR, Santos-Galindo M, Hoozemans JJM, Ferrer I, Rozemuller AJM, Hern\u00e1ndez F, Avila J, Lucas JJ (2014) Huntington\u2019s disease is a four-repeat tauopathy with tau nuclear rods. Nat Med 20:881\u2013885. https:\/\/doi.org\/10.1038\/nm.3617","journal-title":"Nat Med"},{"key":"12314_CR222","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3233\/JHD-230569","volume":"12","author":"I Mees","year":"2023","unstructured":"Mees I, Nisbet RM, Hannan AJ, Renoir T (2023) Implications of tau dysregulation in Huntington\u2019s disease and potential for new therapeutics. J Huntington\u2019s Dis 12:1\u201313. https:\/\/doi.org\/10.3233\/JHD-230569","journal-title":"J Huntington\u2019s Dis"},{"key":"12314_CR223","doi-asserted-by":"publisher","first-page":"1500","DOI":"10.1016\/j.ymthe.2022.01.020","volume":"30","author":"M Alpaugh","year":"2022","unstructured":"Alpaugh M, Masnata M, de Rus Jacquet A, Lepinay E, Denis HL, Saint-Pierre M, Davies P, Planel E, Cicchetti F (2022) Passive immunization against phosphorylated tau improves features of Huntington\u2019s disease pathology. Mol Ther 30:1500\u20131522. https:\/\/doi.org\/10.1016\/j.ymthe.2022.01.020","journal-title":"Mol Ther"},{"key":"12314_CR224","doi-asserted-by":"publisher","first-page":"1997","DOI":"10.1093\/hmg\/ddac001","volume":"31","author":"I Mees","year":"2022","unstructured":"Mees I, Li S, Beauchamp LC, Barnham KJ, Dutschmann M, Hannan AJ, Renoir T (2022) Loss-of-function and gain-of-function studies refute the hypothesis that tau protein is causally involved in the pathogenesis of Huntington\u2019s disease. Hum Mol Genet 31:1997\u20132009. https:\/\/doi.org\/10.1093\/hmg\/ddac001","journal-title":"Hum Mol Genet"},{"key":"12314_CR225","doi-asserted-by":"publisher","first-page":"2456","DOI":"10.1007\/s12035-021-02698-y","volume":"59","author":"I Mees","year":"2022","unstructured":"Mees I, Tran H, Roberts A, Lago L, Li S, Roberts BR, Hannan AJ, Renoir T (2022) Quantitative phosphoproteomics reveals extensive protein phosphorylation dysregulation in the cerebral cortex of Huntington\u2019s disease mice prior to onset of symptoms. Mol Neurobiol 59:2456\u20132471. https:\/\/doi.org\/10.1007\/s12035-021-02698-y","journal-title":"Mol Neurobiol"},{"key":"12314_CR226","doi-asserted-by":"publisher","DOI":"10.1016\/j.cccb.2022.100124","volume":"3","author":"A Biffi","year":"2022","unstructured":"Biffi A (2022) Main features of hereditary cerebral amyloid angiopathies: a systematic review. Cereb Circ Cogn Behav 3:100124. https:\/\/doi.org\/10.1016\/j.cccb.2022.100124","journal-title":"Cereb Circ Cogn Behav"},{"key":"12314_CR227","doi-asserted-by":"publisher","first-page":"6319","DOI":"10.3390\/ijms20246319","volume":"20","author":"P Cisternas","year":"2019","unstructured":"Cisternas P, Taylor X, Lasagna-Reeves CA (2019) The amyloid-tau-neuroinflammation axis in the context of cerebral amyloid angiopathy. Int J Mol Sci 20:6319. https:\/\/doi.org\/10.3390\/ijms20246319","journal-title":"Int J Mol Sci"},{"key":"12314_CR228","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1016\/j.neurobiolaging.2016.12.018","volume":"52","author":"HJ Garringer","year":"2017","unstructured":"Garringer HJ, Sammeta N, Oblak A, Ghetti B, Vidal R (2017) Amyloid and intracellular accumulation of BRI2. Neurobiol Aging 52:90\u201397. https:\/\/doi.org\/10.1016\/j.neurobiolaging.2016.12.018","journal-title":"Neurobiol Aging"},{"key":"12314_CR229","doi-asserted-by":"publisher","first-page":"e56426","DOI":"10.1371\/journal.pone.0056426","volume":"8","author":"HJ Garringer","year":"2013","unstructured":"Garringer HJ, Murrell J, Sammeta N, Gnezda A, Ghetti B, Vidal R (2013) Increased tau phosphorylation and tau truncation, and decreased synaptophysin levels in mutant BRI2\/tau transgenic mice. Chiesa, R., Ed.,. PLoS ONE 8:e56426. https:\/\/doi.org\/10.1371\/journal.pone.0056426","journal-title":"PLoS ONE"},{"key":"12314_CR230","doi-asserted-by":"publisher","first-page":"1599","DOI":"10.1007\/s00018-014-1769-y","volume":"72","author":"M Del Campo","year":"2015","unstructured":"Del Campo M, Oliveira CR, Scheper W, Zwart R, Korth C, M\u00fcller-Schiffmann A, Kostallas G, Biverstal H, Presto J, Johansson J, Hoozemans JJ, Pereira CF, Teunissen CE (2015) BRI2 ectodomain affects A\u03b242 fibrillation and tau truncation in human neuroblastoma cells. Cell Mol Life Sci 72:1599\u20131611. https:\/\/doi.org\/10.1007\/s00018-014-1769-y","journal-title":"Cell Mol Life Sci"},{"key":"12314_CR231","doi-asserted-by":"publisher","first-page":"2111","DOI":"10.1016\/j.stemcr.2022.08.001","volume":"17","author":"MA Fernandez","year":"2022","unstructured":"Fernandez MA, Bah F, Ma L, Lee Y, Schmidt M, Welch E, Morrow EM, Young-Pearse TL (2022) Loss of endosomal exchanger NHE6 leads to pathological changes in tau in human neurons. Stem Cell Reports 17:2111\u20132126. https:\/\/doi.org\/10.1016\/j.stemcr.2022.08.001","journal-title":"Stem Cell Reports"},{"key":"12314_CR232","doi-asserted-by":"publisher","first-page":"3187","DOI":"10.1093\/brain\/awab467","volume":"145","author":"Y Lee","year":"2022","unstructured":"Lee Y, Miller MR, Fernandez MA, Berg EL, Prada AM, Ouyang Q, Schmidt M, Silverman JL, Young-Pearse TL, Morrow EM (2022) Early lysosome defects precede neurodegeneration with amyloid-\u03b2 and tau aggregation in NHE6-null rat brain. Brain 145:3187\u20133202. https:\/\/doi.org\/10.1093\/brain\/awab467","journal-title":"Brain"},{"key":"12314_CR233","doi-asserted-by":"publisher","first-page":"4634","DOI":"10.1038\/s41467-021-24900-4","volume":"12","author":"MP Sch\u00fctzmann","year":"2021","unstructured":"Sch\u00fctzmann MP, Hasecke F, Bachmann S, Zielinski M, H\u00e4nsch S, Schr\u00f6der GF, Zempel H, Hoyer W (2021) Endo-lysosomal A\u03b2 concentration and PH trigger formation of A\u03b2 oligomers that potently induce tau missorting. Nat Commun 12:4634. https:\/\/doi.org\/10.1038\/s41467-021-24900-4","journal-title":"Nat Commun"},{"key":"12314_CR234","doi-asserted-by":"publisher","DOI":"10.1111\/nan.12904","author":"BA Adriaanse","year":"2023","unstructured":"Adriaanse BA, Brady S, Wang M, Beard DJ, Spencer JI, Pansieri J, Sutherland BA, Esiri MM, Buchan AM, Cader Z, Zhang B, DeLuca GC (2023) Tuberous sclerosis complex-1 (TSC1) contributes to selective neuronal vulnerability in Alzheimer\u2019s disease. Neuropathol Appl Neurobiol. https:\/\/doi.org\/10.1111\/nan.12904","journal-title":"Neuropathol Appl Neurobiol"},{"key":"12314_CR235","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1126\/sciadv.abg3897","volume":"7","author":"C Alquezar","year":"2021","unstructured":"Alquezar C, Schoch KM, Geier EG, Ramos EM, Scrivo A, Li KH, Argouarch AR, Mlynarski EE, Dombroski B, DeTure M, Dickson DW, Yokoyama JS, Cuervo AM, Burlingame AL, Schellenberg GD, Miller TM, Miller BL, Kao AW (2021) TSC1 loss increases risk for tauopathy by inducing tau acetylation and preventing tau clearance via chaperone-mediated autophagy. Sci Adv 7:5. https:\/\/doi.org\/10.1126\/sciadv.abg3897","journal-title":"Sci Adv"},{"key":"12314_CR236","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1007\/s00401-017-1764-0","volume":"134","author":"NT Olney","year":"2017","unstructured":"Olney NT, Alquezar C, Ramos EM, Nana AL, Fong JC, Karydas AM, Taylor JB, Stephens ML, Argouarch AR, Van Berlo VA, Dokuru DR, Sherr EH, Jicha GA, Dillon WP, Desikan RS, De May M, Seeley WW, Coppola G, Miller BL, Kao AW (2017) Linking tuberous sclerosis complex, excessive MTOR signaling, and age-related neurodegeneration: a new association between TSC1 mutation and frontotemporal dementia. Acta Neuropathol 134:813\u2013816. https:\/\/doi.org\/10.1007\/s00401-017-1764-0","journal-title":"Acta Neuropathol"},{"key":"12314_CR237","doi-asserted-by":"publisher","first-page":"3206","DOI":"10.1093\/brain\/awad032","volume":"146","author":"PJ McMillan","year":"2023","unstructured":"McMillan PJ, Benbow SJ, Uhrich R, Saxton A, Baum M, Strovas T, Wheeler JM, Baker J, Liachko NF, Keene CD, Latimer CS, Kraemer BC (2023) Tau\u2013RNA complexes inhibit microtubule polymerization and drive disease-relevant conformation change. Brain 146:3206\u20133220. https:\/\/doi.org\/10.1093\/brain\/awad032","journal-title":"Brain"},{"key":"12314_CR238","doi-asserted-by":"publisher","first-page":"e0157540","DOI":"10.1371\/journal.pone.0157540","volume":"11","author":"SM Lee","year":"2016","unstructured":"Lee SM, Chung M, Hyeon JW, Jeong SW, Ju YR, Kim H, Lee J, Kim S, An SSA, Cho SB, Lee YS, Kim SY (2016) Genomic characteristics of genetic Creutzfeldt-Jakob disease patients with V180I mutation and associations with other neurodegenerative disorders. Legname, G., Ed.,. PLoS ONE 11:e0157540. https:\/\/doi.org\/10.1371\/journal.pone.0157540","journal-title":"PLoS ONE"},{"key":"12314_CR239","doi-asserted-by":"publisher","first-page":"4170","DOI":"10.1007\/s12035-020-02025-x","volume":"57","author":"L Lid\u00f3n","year":"2020","unstructured":"Lid\u00f3n L, Vergara C, Ferrer I, Hern\u00e1ndez F, \u00c1vila J, del Rio JA, Gav\u00edn R (2020) Tau protein as a new regulator of cellular prion protein transcription. Mol Neurobiol 57:4170\u20134186. https:\/\/doi.org\/10.1007\/s12035-020-02025-x","journal-title":"Mol Neurobiol"},{"key":"12314_CR240","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1186\/s13195-022-01033-4","volume":"14","author":"Z Chen","year":"2022","unstructured":"Chen Z, Chu M, Liu L, Zhang J, Kong Y, Xie K, Cui Y, Ye H, Li J, Wang L, Wu L (2022) Genetic prion diseases presenting as frontotemporal dementia: clinical features and diagnostic challenge. Alzheimer\u2019s Res Ther 14:90. https:\/\/doi.org\/10.1186\/s13195-022-01033-4","journal-title":"Alzheimer\u2019s Res Ther"},{"key":"12314_CR241","doi-asserted-by":"publisher","first-page":"389","DOI":"10.12998\/wjcc.v7.i3.389","volume":"7","author":"M-M Zhao","year":"2019","unstructured":"Zhao M-M, Feng L-S, Hou S, Shen P-P, Cui L, Feng J-C (2019) Gerstmann\u2013Str\u00e4ussler\u2013Scheinker disease: a case report. World J Clin Cases 7:389\u2013395. https:\/\/doi.org\/10.12998\/wjcc.v7.i3.389","journal-title":"World J Clin Cases"},{"key":"12314_CR242","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1186\/s40478-018-0608-z","volume":"6","author":"SL Risacher","year":"2018","unstructured":"Risacher SL, Farlow MR, Bateman DR, Epperson F, Tallman EF, Richardson R, Murrell JR, Unverzagt FW, Apostolova LG, Bonnin JM, Ghetti B, Saykin AJ (2018) Detection of tau in Gerstmann\u2013Str\u00e4ussler\u2013Scheinker disease (PRNP F198S) by [18F]Flortaucipir PET. Acta Neuropathol Commun 6:114. https:\/\/doi.org\/10.1186\/s40478-018-0608-z","journal-title":"Acta Neuropathol Commun"},{"key":"12314_CR243","doi-asserted-by":"publisher","first-page":"15755","DOI":"10.3390\/ijms232415755","volume":"23","author":"Y Riku","year":"2022","unstructured":"Riku Y, Yoshida M, Iwasaki Y, Sobue G, Katsuno M, Ishigaki S (2022) TDP-43 proteinopathy and tauopathy: do they have pathomechanistic links? Int J Mol Sci 23:15755. https:\/\/doi.org\/10.3390\/ijms232415755","journal-title":"Int J Mol Sci"},{"key":"12314_CR244","doi-asserted-by":"publisher","first-page":"e1004803","DOI":"10.1371\/journal.pgen.1004803","volume":"10","author":"NF Liachko","year":"2014","unstructured":"Liachko NF, McMillan PJ, Strovas TJ, Loomis E, Greenup L, Murrell JR, Ghetti B, Raskind MA, Montine TJ, Bird TD, Leverenz JB, Kraemer BC (2014) The tau tubulin kinases TTBK1\/2 promote accumulation of pathological TDP-43. Jackson, G.R., Ed.,. PLoS Genet 10:e1004803. https:\/\/doi.org\/10.1371\/journal.pgen.1004803","journal-title":"PLoS Genet"},{"key":"12314_CR245","doi-asserted-by":"publisher","DOI":"10.1111\/nan.12778","author":"S Koga","year":"2022","unstructured":"Koga S, Zhou X, Murakami A, Fernandez De Castro C, Baker MC, Rademakers R, Dickson DW (2022) Concurrent tau pathologies in frontotemporal lobar degeneration with TDP-43 pathology. Neuropathol Appl Neurobiol. https:\/\/doi.org\/10.1111\/nan.12778","journal-title":"Neuropathol Appl Neurobiol"},{"key":"12314_CR246","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1186\/s13024-023-00653-0","volume":"18","author":"SO Tom\u00e9","year":"2023","unstructured":"Tom\u00e9 SO, Tsaka G, Ronisz A, Ospitalieri S, Gawor K, Gomes LA, Otto M, von Arnim CAF, Van Damme P, Van Den Bosch L, Ghebremedhin E, Laureyssen C, Sleegers K, Vandenberghe R, Rousseau F, Schymkowitz J, Thal DR (2023) TDP-43 pathology is associated with increased tau burdens and seeding. Mol Neurodegener 18:71. https:\/\/doi.org\/10.1186\/s13024-023-00653-0","journal-title":"Mol Neurodegener"},{"key":"12314_CR247","doi-asserted-by":"publisher","DOI":"10.1126\/science.aay8826","author":"NF Darwich","year":"2020","unstructured":"Darwich NF, Phan JM, Kim B, Suh E, Papatriantafyllou JD, Changolkar L, Nguyen AT, O\u2019Rourke CM, He Z, Porta S, Gibbons GS, Luk KC, Papageorgiou SG, Grossman M, Massimo L, Irwin DJ, McMillan CT, Nasrallah IM, Toro C, Aguirre GK, Van Deerlin VM, Lee EB (2020) Autosomal dominant VCP hypomorph mutation impairs disaggregation of PHF-tau. Science. https:\/\/doi.org\/10.1126\/science.aay8826","journal-title":"Science"},{"key":"12314_CR248","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1093\/hmg\/ddl463","volume":"16","author":"PD Sundar","year":"2007","unstructured":"Sundar PD, Yu C-E, Sieh W, Steinbart E, Garruto RM, Oyanagi K, Craig U-K, Bird TD, Wijsman EM, Galasko DR, Schellenberg GD (2007) Two sites in the MAPT region confer genetic risk for guam ALS\/PDC and dementia. Hum Mol Genet 16:295\u2013306. https:\/\/doi.org\/10.1093\/hmg\/ddl463","journal-title":"Hum Mol Genet"},{"key":"12314_CR249","doi-asserted-by":"publisher","first-page":"11510","DOI":"10.1073\/pnas.0505149102","volume":"102","author":"MC Hermosura","year":"2005","unstructured":"Hermosura MC, Nayakanti H, Dorovkov MV, Calderon FR, Ryazanov AG, Haymer DS, Garruto RM (2005) A TRPM7 variant shows altered sensitivity to magnesium that may contribute to the pathogenesis of two guamanian neurodegenerative disorders. Proc Natl Acad Sci 102:11510\u201311515. https:\/\/doi.org\/10.1073\/pnas.0505149102","journal-title":"Proc Natl Acad Sci"},{"key":"12314_CR250","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1126\/scisignal.ade6325","volume":"16","author":"S Zhang","year":"2023","unstructured":"Zhang S, Cao F, Li W, Abumaria N (2023) TRPM7 kinase activity induces amyloid-\u03b2 degradation to reverse synaptic and cognitive deficits in mouse models of Alzheimer\u2019s disease. Sci Signaling 16:5. https:\/\/doi.org\/10.1126\/scisignal.ade6325","journal-title":"Sci Signaling"},{"key":"12314_CR251","doi-asserted-by":"publisher","first-page":"1409","DOI":"10.1002\/mds.23085","volume":"25","author":"P Poorkaj","year":"2010","unstructured":"Poorkaj P, Raskind WH, Leverenz JB, Matsushita M, Zabetian CP, Samii A, Kim S, Gazi N, Nutt JG, Wolff J, Yearout D, Greenup JL, Steinbart EJ, Bird TD (2010) A novel X-linked four-repeat tauopathy with Parkinsonism and spasticity. Mov Disord 25:1409\u20131417. https:\/\/doi.org\/10.1002\/mds.23085","journal-title":"Mov Disord"},{"key":"12314_CR252","doi-asserted-by":"publisher","first-page":"3259","DOI":"10.1093\/hmg\/ddt180","volume":"22","author":"O Korvatska","year":"2013","unstructured":"Korvatska O, Strand NS, Berndt JD, Strovas T, Chen D-H, Leverenz JB, Kiianitsa K, Mata IF, Karakoc E, Greenup JL, Bonkowski E, Chuang J, Moon RT, Eichler EE, Nickerson DA, Zabetian CP, Kraemer BC, Bird TD, Raskind WH (2013) Altered splicing of ATP6AP2 causes X-linked Parkinsonism with spasticity (XPDS). Hum Mol Genet 22:3259\u20133268. https:\/\/doi.org\/10.1093\/hmg\/ddt180","journal-title":"Hum Mol Genet"},{"key":"12314_CR253","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1016\/j.ajhg.2011.09.007","volume":"89","author":"MB Hartig","year":"2011","unstructured":"Hartig MB, Iuso A, Haack T, Kmiec T, Jurkiewicz E, Heim K, Roeber S, Tarabin V, Dusi S, Krajewska-Walasek M, Jozwiak S, Hempel M, Winkelmann J, Elstner M, Oexle K, Klopstock T, Mueller-Felber W, Gasser T, Trenkwalder C, Tiranti V, Kretzschmar H, Schmitz G, Strom TM, Meitinger T, Prokisch H (2011) Absence of an orphan mitochondrial protein, C19orf12, causes a distinct clinical subtype of neurodegeneration with brain iron accumulation. Am J Hum Genetics 89:543\u2013550. https:\/\/doi.org\/10.1016\/j.ajhg.2011.09.007","journal-title":"Am J Hum Genetics"},{"key":"12314_CR254","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1002\/alz.046690","volume":"16","author":"V Nguyen","year":"2020","unstructured":"Nguyen V, Garcia D, Setthavongsack N, Shirley K, Krajbich V, Clark D, van der Weijden M, Zhen D, Wakeman K, Jeong SY, Freed A, Gregory A, Hogarth P, Hayflick S, Woltjer R (2020) Secondary tauopathy in a genetic synucleinopathy, mitochondrial protein-associated neurodegeneration (MPAN). Alzheimer\u2019s Dementia 16:5. https:\/\/doi.org\/10.1002\/alz.046690","journal-title":"Alzheimer\u2019s Dementia"},{"key":"12314_CR255","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1212\/NXG.0000000000000515","volume":"6","author":"P Balicza","year":"2020","unstructured":"Balicza P, Bencsik R, Lengyel A, Gal A, Grosz Z, Csaban D, Rudas G, Danics K, Kovacs GG, Molnar MJ (2020) Novel dominant MPAN family with a complex genetic architecture as a basis for phenotypic variability. Neurol Genet 6:4. https:\/\/doi.org\/10.1212\/NXG.0000000000000515","journal-title":"Neurol Genet"},{"key":"12314_CR256","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1111\/neup.12894","volume":"43","author":"Y Yonenobu","year":"2023","unstructured":"Yonenobu Y, Beck G, Kido K, Maeda N, Yamashita R, Inoue K, Saito Y, Hasegawa M, Ito H, Hasegawa K, Morii E, Iwaki T, Murayama S, Mochizuki H (2023) Neuropathology of spinocerebellar ataxia type 8: common features and unique tauopathy. Neuropathology 43:351\u2013361. https:\/\/doi.org\/10.1111\/neup.12894","journal-title":"Neuropathology"},{"key":"12314_CR257","doi-asserted-by":"publisher","first-page":"2386","DOI":"10.1080\/15548627.2023.2175569","volume":"19","author":"JM Carosi","year":"2023","unstructured":"Carosi JM, Sargeant TJ (2023) Rapamycin and Alzheimer disease: a hypothesis for the effective use of rapamycin for treatment of neurodegenerative disease. Autophagy 19:2386\u20132390. https:\/\/doi.org\/10.1080\/15548627.2023.2175569","journal-title":"Autophagy"},{"key":"12314_CR258","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1111\/bpa.13069","volume":"32","author":"H Miyahara","year":"2022","unstructured":"Miyahara H, Akagi A, Riku Y, Sone J, Otsuka Y, Sakai M, Kuru S, Hasegawa M, Yoshida M, Kakita A, Iwasaki Y (2022) Independent distribution between tauopathy secondary to subacute sclerotic panencephalitis and measles virus: an immunohistochemical analysis in autopsy cases including cases treated with aggressive antiviral therapies. Brain Pathol 32:4. https:\/\/doi.org\/10.1111\/bpa.13069","journal-title":"Brain Pathol"},{"key":"12314_CR259","doi-asserted-by":"publisher","first-page":"886","DOI":"10.1016\/j.neuron.2012.11.021","volume":"76","author":"K Blennow","year":"2012","unstructured":"Blennow K, Hardy J, Zetterberg H (2012) The neuropathology and neurobiology of traumatic brain injury. Neuron 76:886\u2013899. https:\/\/doi.org\/10.1016\/j.neuron.2012.11.021","journal-title":"Neuron"},{"key":"12314_CR260","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1089\/neu.2018.6348","volume":"37","author":"G Edwards","year":"2020","unstructured":"Edwards G, Zhao J, Dash PK, Soto C, Moreno-Gonzalez I (2020) Traumatic brain injury induces tau aggregation and spreading. J Neurotrauma 37:80\u201392. https:\/\/doi.org\/10.1089\/neu.2018.6348","journal-title":"J Neurotrauma"},{"key":"12314_CR261","doi-asserted-by":"publisher","first-page":"4","DOI":"10.3389\/fneur.2019.00980","volume":"10","author":"A Katsumoto","year":"2019","unstructured":"Katsumoto A, Takeuchi H, Tanaka F (2019) Tau pathology in chronic traumatic encephalopathy and Alzheimer\u2019s disease: similarities and differences. Front Neurol 10:4. https:\/\/doi.org\/10.3389\/fneur.2019.00980","journal-title":"Front Neurol"},{"key":"12314_CR262","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1038\/s41536-020-00114-y","volume":"6","author":"D Cortes","year":"2021","unstructured":"Cortes D, Pera MF (2021) The genetic basis of inter-individual variation in recovery from traumatic brain injury. npj Regener Med 6:5. https:\/\/doi.org\/10.1038\/s41536-020-00114-y","journal-title":"npj Regener Med"},{"key":"12314_CR263","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1016\/j.neuroscience.2010.04.037","volume":"169","author":"HN Dawson","year":"2010","unstructured":"Dawson HN, Cantillana V, Jansen M, Wang H, Vitek MP, Wilcock DM, Lynch JR, Laskowitz DT (2010) Loss of tau elicits axonal degeneration in a mouse model of Alzheimer\u2019s disease. Neuroscience 169:516\u2013531. https:\/\/doi.org\/10.1016\/j.neuroscience.2010.04.037","journal-title":"Neuroscience"},{"key":"12314_CR264","doi-asserted-by":"publisher","first-page":"2715","DOI":"10.1016\/j.cell.2021.03.032","volume":"184","author":"M-K Shin","year":"2021","unstructured":"Shin M-K, V\u00e1zquez-Rosa E, Koh Y, Dhar M, Chaubey K, Cintr\u00f3n-P\u00e9rez CJ, Barker S, Miller E, Franke K, Noterman MF, Seth D, Allen RS, Motz CT, Rao SR, Skelton LA, Pardue MT, Fliesler SJ, Wang C, Tracy TE, Gan L, Liebl DJ, Savarraj JPJ, Torres GL, Ahnstedt H, McCullough LD, Kitagawa RS, Choi HA, Zhang P, Hou Y, Chiang C-W, Li L, Ortiz F, Kilgore JA, Williams NS, Whitehair VC, Gefen T, Flanagan ME, Stamler JS, Jain MK, Kraus A, Cheng F, Reynolds JD, Pieper AA (2021) Reducing acetylated tau is neuroprotective in brain injury. Cell 184:2715-2732.e23. https:\/\/doi.org\/10.1016\/j.cell.2021.03.032","journal-title":"Cell"},{"key":"12314_CR265","doi-asserted-by":"publisher","first-page":"1017","DOI":"10.4103\/1673-5374.355742","volume":"18","author":"Y-Z Zhang","year":"2023","unstructured":"Zhang Y-Z, Ni Y, Gao Y-N, Shen D-D, He L, Yin D, Meng H-Y, Zhou Q-M, Hu J, Chen S (2023) Anti-IgLON5 disease: a novel topic beyond neuroimmunology. Neural Regen Res 18:1017. https:\/\/doi.org\/10.4103\/1673-5374.355742","journal-title":"Neural Regen Res"},{"key":"12314_CR266","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1016\/S1474-4422(14)70051-1","volume":"13","author":"L Sabater","year":"2014","unstructured":"Sabater L, Gaig C, Gelpi E, Bataller L, Lewerenz J, Torres-Vega E, Contreras A, Giometto B, Compta Y, Embid C, Vilaseca I, Iranzo A, Santamar\u00eda J, Dalmau J, Graus F (2014) A novel non-rapid-eye movement and rapid-eye-movement parasomnia with sleep breathing disorder associated with antibodies to IgLON5: a case series, characterisation of the antigen, and post-mortem study. Lancet Neurol 13:575\u2013586. https:\/\/doi.org\/10.1016\/S1474-4422(14)70051-1","journal-title":"Lancet Neurol"},{"key":"12314_CR267","doi-asserted-by":"publisher","first-page":"5","DOI":"10.3389\/fnmol.2018.00008","volume":"11","author":"K Karis","year":"2018","unstructured":"Karis K, Eskla K-L, Kaare M, T\u00e4ht K, Tuusov J, Visnapuu T, Innos J, Jayaram M, Timmusk T, Weickert CS, V\u00e4li M, Vasar E, Philips M-A (2018) Altered expression profile of IgLON family of neural cell adhesion molecules in the dorsolateral prefrontal cortex of schizophrenic patients. Front Mol Neurosci 11:5. https:\/\/doi.org\/10.3389\/fnmol.2018.00008","journal-title":"Front Mol Neurosci"},{"key":"12314_CR268","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1186\/s12974-022-02520-z","volume":"19","author":"Y Ni","year":"2022","unstructured":"Ni Y, Feng Y, Shen D, Chen M, Zhu X, Zhou Q, Gao Y, Liu J, Zhang Q, Shen Y, Peng L, Zeng Z, Yin D, Hu J, Chen S (2022) Anti-IgLON5 antibodies cause progressive behavioral and neuropathological changes in mice. J Neuroinflamm 19:140. https:\/\/doi.org\/10.1186\/s12974-022-02520-z","journal-title":"J Neuroinflamm"},{"key":"12314_CR269","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1007\/s00401-016-1591-8","volume":"132","author":"E Gelpi","year":"2016","unstructured":"Gelpi E, H\u00f6ftberger R, Graus F, Ling H, Holton JL, Dawson T, Popovic M, Pretnar-Oblak J, H\u00f6gl B, Schmutzhard E, Poewe W, Ricken G, Santamaria J, Dalmau J, Budka H, Revesz T, Kovacs GG (2016) Neuropathological criteria of anti-IgLON5-related tauopathy. Acta Neuropathol 132:531\u2013543. https:\/\/doi.org\/10.1007\/s00401-016-1591-8","journal-title":"Acta Neuropathol"},{"key":"12314_CR270","doi-asserted-by":"publisher","first-page":"837","DOI":"10.3390\/cells10040837","volume":"10","author":"M Ryding","year":"2021","unstructured":"Ryding M, Gamre M, Nissen MS, Nilsson AC, Okarmus J, Poulsen AAE, Meyer M, Blaabjerg M (2021) Neurodegeneration induced by anti-IgLON5 antibodies studied in induced pluripotent stem cell-derived human neurons. Cells 10:837. https:\/\/doi.org\/10.3390\/cells10040837","journal-title":"Cells"},{"key":"12314_CR271","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000207870","author":"H Theis","year":"2023","unstructured":"Theis H, Bischof GN, Br\u00fcggemann N, Dargvainiene J, Drzezga A, Gr\u00fcter T, Lewerenz J, Leypoldt F, Neumaier B, Wandinger K-P, Ayzenberg I, van Eimeren T (2023) In Vivo measurement of tau depositions in anti-IgLON5 disease using [18F]PI-2620 PET. Neurology. https:\/\/doi.org\/10.1212\/WNL.0000000000207870","journal-title":"Neurology"},{"key":"12314_CR272","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1007\/s00401-023-02625-6","volume":"146","author":"E Berger-Sieczkowski","year":"2023","unstructured":"Berger-Sieczkowski E, Endmayr V, Haider C, Ricken G, Jauk P, Macher S, Pirker W, H\u00f6gl B, Heidbreder A, Schnider P, Bradley-Zechmeister E, Mariotto S, Koneczny I, Reinecke R, Kasprian G, Weber C, Bergmann M, Milenkovic I, Berger T, Gaig C, Sabater L, Graus F, Gelpi E, H\u00f6ftberger R (2023) Analysis of inflammatory markers and tau deposits in an autopsy series of nine patients with anti-IgLON5 disease. Acta Neuropathol 146:631\u2013645. https:\/\/doi.org\/10.1007\/s00401-023-02625-6","journal-title":"Acta Neuropathol"},{"key":"12314_CR273","doi-asserted-by":"publisher","DOI":"10.1212\/NXI.0000000000000605","volume":"6","author":"C Gaig","year":"2019","unstructured":"Gaig C, Ercilla G, Daura X, Ezquerra M, Fern\u00e1ndez-Santiago R, Palou E, Sabater L, H\u00f6ftberger R, Heidbreder A, H\u00f6gl B, Iranzo A, Santamaria J, Dalmau J, Graus F (2019) HLA and microtubule-associated protein tau H1 haplotype associations in anti-IgLON5 disease. Neurol Neuroimmunol Neuroinflamm 6:e605. https:\/\/doi.org\/10.1212\/NXI.0000000000000605","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"12314_CR274","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1016\/j.jmb.2018.12.008","volume":"431","author":"AY Roman","year":"2019","unstructured":"Roman AY, Devred F, Byrne D, La Rocca R, Ninkina NN, Peyrot V, Tsvetkov PO (2019) Zinc induces temperature-dependent reversible self-assembly of tau. J Mol Biol 431:687\u2013695. https:\/\/doi.org\/10.1016\/j.jmb.2018.12.008","journal-title":"J Mol Biol"},{"key":"12314_CR275","doi-asserted-by":"publisher","first-page":"1293","DOI":"10.1212\/WNL.0000000000001997","volume":"85","author":"D Caparros-Lefebvre","year":"2015","unstructured":"Caparros-Lefebvre D, Golbe LI, Deramecourt V, Maurage C-A, Huin V, Bu\u00e9e-Scherrer V, Obriot H, Sablonni\u00e8re B, Caparros F, Bu\u00e9e L, Lees AJ (2015) A geographical cluster of progressive supranuclear palsy in Northern France. Neurology 85:1293\u20131300. https:\/\/doi.org\/10.1212\/WNL.0000000000001997","journal-title":"Neurology"},{"key":"12314_CR276","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1007\/s00401-006-0053-0","volume":"111","author":"MJ Winton","year":"2006","unstructured":"Winton MJ, Joyce S, Zhukareva V, Practico D, Perl DP, Galasko D, Craig U, Trojanowski JQ, Lee VM-Y (2006) Characterization of tau pathologies in gray and white matter of Guam Parkinsonism-dementia complex. Acta Neuropathol 111:401\u2013412. https:\/\/doi.org\/10.1007\/s00401-006-0053-0","journal-title":"Acta Neuropathol"},{"key":"12314_CR277","doi-asserted-by":"publisher","first-page":"5074","DOI":"10.1073\/pnas.0501526102","volume":"102","author":"PA Cox","year":"2005","unstructured":"Cox PA, Banack SA, Murch SJ, Rasmussen U, Tien G, Bidigare RR, Metcalf JS, Morrison LF, Codd GA, Bergman B (2005) Diverse taxa of cyanobacteria produce \u03b2- N -methylamino- l -alanine, a neurotoxic amino acid. Proc Natl Acad Sci 102:5074\u20135078. https:\/\/doi.org\/10.1073\/pnas.0501526102","journal-title":"Proc Natl Acad Sci"},{"key":"12314_CR278","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1016\/S0140-6736(98)10166-6","volume":"354","author":"D Caparros-Lefebvre","year":"1999","unstructured":"Caparros-Lefebvre D, Elbaz A (1999) Possible relation of atypical Parkinsonism in the French west indies with consumption of tropical plants: a case-control study. The Lancet 354:281\u2013286. https:\/\/doi.org\/10.1016\/S0140-6736(98)10166-6","journal-title":"The Lancet"},{"key":"12314_CR279","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.jocn.2019.06.041","volume":"67","author":"C Marques Matos","year":"2019","unstructured":"Marques Matos C, Alonso I, Le\u00e3o M (2019) Diagnostic yield of next-generation sequencing applied to neurological disorders. J Clin Neurosci 67:14\u201318. https:\/\/doi.org\/10.1016\/j.jocn.2019.06.041","journal-title":"J Clin Neurosci"},{"key":"12314_CR280","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1016\/S1474-4422(19)30033-X","volume":"18","author":"J Rexach","year":"2019","unstructured":"Rexach J, Lee H, Martinez-Agosto JA, N\u00e9meth AH, Fogel BL (2019) Clinical application of next-generation sequencing to the practice of neurology. Lancet Neurol 18:492\u2013503. https:\/\/doi.org\/10.1016\/S1474-4422(19)30033-X","journal-title":"Lancet Neurol"}],"container-title":["Journal of Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-024-12314-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00415-024-12314-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-024-12314-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,29]],"date-time":"2024-05-29T15:16:34Z","timestamp":1716995794000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00415-024-12314-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3,30]]},"references-count":280,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2024,6]]}},"alternative-id":["12314"],"URL":"https:\/\/doi.org\/10.1007\/s00415-024-12314-3","relation":{},"ISSN":["0340-5354","1432-1459"],"issn-type":[{"value":"0340-5354","type":"print"},{"value":"1432-1459","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,3,30]]},"assertion":[{"value":"25 January 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 March 2024","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 March 2024","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 March 2024","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"T. van Eimeren is a civil servant of North Rhine-Westphalia (Germany) and employee of the University Hospital of Cologne, Germany. In the last 2 years, he received honoraria, stipends or speaker fees from the Lundbeck Foundation, Gain Therapeutics, Orion Pharma, Lundbeck Pharma, Atheneum, and the International Movement Disorders Society. He receives materials from Life Molecular Imaging and Lilly Pharma. He owns stocks of the corporations NVIDIA, Microsoft and I.B.M. Multiple unrelated research projects are currently supported by the German Research Foundation.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}}]}}